<SEC-DOCUMENT>0001193125-20-178254.txt : 20200625
<SEC-HEADER>0001193125-20-178254.hdr.sgml : 20200625
<ACCEPTANCE-DATETIME>20200625071711
ACCESSION NUMBER:		0001193125-20-178254
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20200622
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200625
DATE AS OF CHANGE:		20200625

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HENRY SCHEIN INC
		CENTRAL INDEX KEY:			0001000228
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
		IRS NUMBER:				113136595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1226

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27078
		FILM NUMBER:		20987048

	BUSINESS ADDRESS:	
		STREET 1:		135 DURYEA RD
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6318435500

	MAIL ADDRESS:	
		STREET 1:		135 DURYEA RD
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCHEIN HENRY INC
		DATE OF NAME CHANGE:	19950907
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d948426d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hsic="http://henryschein.com/20200622" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-06-22_to_2020-06-22">HENRY SCHEIN INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-06-22_to_2020-06-22">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-06-22_to_2020-06-22">0001000228</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hsic-20200622.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-06-22_to_2020-06-22"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000228</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-06-22</xbrli:startDate> <xbrli:endDate>2020-06-22</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">WASHINGTON, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-06-22_to_2020-06-22">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt:datemonthdayyearen">June&#160;22, 2020</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:12pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Henry Schein, Inc.</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-06-22_to_2020-06-22">0-27078</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-06-22_to_2020-06-22">11-3136595</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr></table>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:50%;"></td>
<td style="width:1%;"></td>
<td style="width:48%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-06-22_to_2020-06-22">135 Duryea Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-06-22_to_2020-06-22">Melville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-06-22_to_2020-06-22">11747</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Zip Code)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-06-22_to_2020-06-22">(631)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-06-22_to_2020-06-22">843-5500</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0px;margin-top:12pt">(Former name or former address, if changed since last report.)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-06-22_to_2020-06-22">Common Stock, par value $.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-06-22_to_2020-06-22">HSIC</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR &#167;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;text-align:right;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-06-22_to_2020-06-22" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;1.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Entry into a Material Definitive Agreement.</td> </tr> </table> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">Amendment of Existing Private Placement Shelf Facilities </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">On June&#160;23, 2020, Henry Schein, Inc. (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;) amended its (i)&#160;Second Amended and Restated Multicurrency Private Shelf Agreement, dated as of June&#160;29, 2018, by and among the Company, PGIM, Inc. (&#8220;<span style="text-decoration:underline">Prudential</span>&#8221;) and each Prudential affiliate which becomes party thereto, (ii)&#160;Second Amended and Restated Master Note Facility, dated as of June&#160;29, 2018, by and among the Company, NYL Investors LLC (as successor in interest to New York Life Investment Management LLC) (&#8220;<span style="text-decoration:underline">New York Life</span>&#8221;) and each New York Life affiliate which becomes party thereto, and (iii)&#160;Second Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of June&#160;29, 2018, by and among the Company, Metropolitan Life Insurance Company (&#8220;<span style="text-decoration:underline">MLIC</span>&#8221;), MetLife Investment Management, LLC (as successor in interest to MetLife Investment Advisors Company, LLC) (&#8220;<span style="text-decoration:underline">MLIAC</span>,&#8221; and together with MLIC, &#8220;<span style="text-decoration:underline">MetLife</span>&#8221;) and each MetLife affiliate which becomes party thereto (the amendments listed in clauses (i)&#160;through (iii) above, collectively, the &#8220;<span style="text-decoration:underline">Private Shelf Amendments</span>&#8221;), in each case, to, among other things, (A)&#160;extend the scheduled facility termination dates to June&#160;23, 2023, (B) temporarily modify the financial covenant from being based on total leverage ratio to net leverage ratio until March&#160;31, 2021, (C)&#160;increase the maximum maintenance leverage ratio through March&#160;31, 2021, but with a 1.00% interest rate increase on the outstanding notes if the net leverage ratio exceeds 3.0x, which will remain in effect until the Company delivers financials for a four-quarter period ending on or after June&#160;30, 2021 showing compliance with the total leverage ratio requirement, and (D)&#160;make certain other changes conforming to the Revolving Credit Agreement, dated as of April&#160;18, 2017 (as amended by that certain First Amendment, dated as of June&#160;29, 2018, and that certain Second Amendment, dated as of April&#160;17, 2020), by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders and other agents party thereto. </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">The above description of the Private Shelf Amendments is not complete and is qualified in its entirety by the actual terms of the Private Shelf Amendments, copies of which are attached hereto as Exhibit 4.1, Exhibit 4.2 and Exhibit 4.3, respectively, and are incorporated herein by reference. </p> <p style="font-family:Times New Roman;font-style:italic;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Amendments to Existing&#160;Receivables Purchase Agreement </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">On June&#160;22, 2020, the Company amended its&#160;Receivables Purchase Agreement,&#160;dated as of April&#160;17, 2013 (as amended by that certain Omnibus Amendment No.&#160;1, dated as of July&#160;22, 2013, that certain Omnibus Amendment No.&#160;2, dated as of April&#160;21, 2014, that certain Amendment No.&#160;1 to Receivables Purchase Agreement, dated as of September&#160;22, 2014, that certain Amendment No.&#160;2 to Receivables Purchase Agreement, dated as of April&#160;14, 2015, that certain Amendment No.&#160;3 to Receivables Purchase Agreement, dated as of June&#160;1, 2016, that certain Amendment No.&#160;4 to Receivables Purchase Agreement, dated as of July&#160;6, 2017, and that certain Amendment No.&#160;5 to Receivables Purchase Agreement, dated as of March&#160;13, 2019), by and among the Company, as servicer, HSFR, Inc., as seller, the existing lender, as agent and the various purchaser groups from time to time party thereto, to, among other things, extend the scheduled facility termination date to June&#160;12, 2023 and adjust certain covenant levels, in particular for the second and third quarters of 2020 (the &#8220;<span style="text-decoration:underline">Receivables Amendment</span>&#8221;). </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">The foregoing description of the Receivables Amendment in this Form <span style="white-space:nowrap">8-K</span> is not complete and is qualified in its entirety by the actual terms of the Receivables Amendment, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;2.03 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">The information required by this Item is included in Item&#160;1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;7.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Regulation FD Disclosure.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">On June&#160;25, 2020, the Company issued a press release announcing the Private Shelf Amendments and the Receivables Amendment. </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> Such press release shall not be deemed &#8220;filed&#8221; for any purpose, including for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration:underline">Exchange Act</span>&#8221;), or otherwise subject to the liabilities of that Section. The information in Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing. </p> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d) Exhibits. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:3%;"></td>
<td style="width:88%;"></td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d948426dex41.htm">First Amendment to Second Amended and Restated Multicurrency Private Shelf Agreement, dated as of June&#160;23, 2020, by and among the Company, PGIM, Inc. and each Prudential affiliate which becomes party thereto</a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.2 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d948426dex42.htm">First Amendment to Second Amended and Restated Master Note Facility, dated as of June&#160;23, 2020, by and among the Company, NYL Investors LLC and each New York Life affiliate which becomes party thereto</a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.3 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d948426dex43.htm">First Amendment to Second Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of June&#160;23, 2020, by and among the Company, Metropolitan Life Insurance Company, MetLife Investment Management, LLC and each MetLife affiliate which becomes party thereto</a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">10.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d948426dex101.htm">Amendment No.&#160;6 dated as of June&#160;22, 2020, to the Receivables Purchase Agreement, dated as of April&#160;17, 2013, by and among the Company, as servicer, HSFR, Inc., as seller, Lender, as agent and the various purchaser groups from time to time party thereto, as amended</a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Exhibit&#160;99.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d948426dex991.htm">Press Release dated June&#160;25, 2020 </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Exhibit 104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document) </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:47%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:47%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="3" style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">HENRY SCHEIN, INC.</span> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Date: June&#160;25, 2020 </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Walter Siegel </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name: </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Walter Siegel </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title: </p> </td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Senior Vice President and General Counsel </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>
 </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d948426dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FIRST
AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY PRIVATE SHELF AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED
MULTICURRENCY PRIVATE SHELF AGREEMENT, dated as of June&nbsp;23, 2020 (this &#147;<U>Amendment</U>&#148;), is among Henry Schein, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), PGIM, Inc., a New Jersey corporation
(&#147;<U>Prudential</U>&#148;), and the other financial institutions and other entities party hereto (the &#147;<U>Holders</U>&#148;) that constitute each of the holders of the Notes outstanding as of the date hereof (such Notes, the
&#147;<U>Existing Notes</U>&#148;, and as amended and restated by this Amendment, and as may be further amended, restated, modified or replaced from time to time, together with any notes issued in substitution therefor pursuant to Section&nbsp;13 of
the Note Facility (as defined below), collectively, the &#147;<U>Notes</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W I T N E S S E T H </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, reference is made to that certain $500,000,000 Second Amended and Restated Multicurrency Private Shelf Agreement, dated as of
June&nbsp;29, 2018, by and among the Company, Prudential and each Holder party thereto (as amended, restated, modified, or supplemented from time to time, the &#147;<U>Note Facility</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has requested that the Note Facility be amended by this Amendment in order to, among other things, (i)&nbsp;extend the
Issuance Period and (ii)&nbsp;effect certain changes to the covenant set forth in Section&nbsp;10.9 of the Note Facility; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company,
Prudential and the Holders are willing to enter into such amendments subject and pursuant to the terms and conditions of this Amendment; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined Terms</U>. Unless otherwise defined herein, capitalized terms used but not defined herein
shall have the meanings assigned to such terms in the Note Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment to the Note
Facility</U>. Effective as of the First Amendment Effective Date, the Note Facility is hereby amended as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each reference to $200,000,000 (or the Dollar Equivalent in other Available Currencies)&#148; in the Note Facility
is hereby amended and restated in its entirety as follows &#147;$500,000,000 (or the Dollar Equivalent in other Available Currencies)&#148;. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Section 2.1 of the Note Facility is hereby amended and restated
in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>2.1. Facility. </B>Prudential is willing to consider, in its sole discretion and within the limits
which may be authorized for purchase by Prudential Affiliates from time to time, the purchase of Shelf Notes pursuant to this Agreement. The willingness of Prudential to consider such purchase of Shelf Notes is herein called the
&#147;<B>Facility</B>&#148;. At any time the aggregate principal amount of Shelf Notes in Section&nbsp;1.4, minus the aggregate principal amount of Shelf Notes purchased and sold pursuant to this Agreement and outstanding at such time, minus the
aggregate principal amount of Accepted Notes (as hereinafter defined) which have not yet been purchased and sold hereunder prior to such time, is herein called the &#147;<B>Available Facility Amount</B>&#148; at such time. For the purposes of the
preceding sentence, all aggregate principal amounts of Shelf Notes and Accepted Notes shall be calculated in Dollars; with respect to any Shelf Notes denominated or Accepted Notes to be denominated in any Available Currency other than Dollars, the
Dollar Equivalent of Shelf Notes or Accepted Notes shall be used for such calculation. For the avoidance of doubt, the Available Facility Amount shall be increased by the principal amount of any outstanding Notes which are repaid or prepaid prior to
the expiration of the Issuance Period (but in no event shall the Available Facility Amount exceed $500,000,000 at any time). <B>NOTWITHSTANDING THE WILLINGNESS OF PRUDENTIAL TO CONSIDER PURCHASES OF SHELF NOTES BY PRUDENTIAL AFFILIATES, THIS
AGREEMENT IS ENTERED INTO ON THE EXPRESS UNDERSTANDING THAT NEITHER PRUDENTIAL NOR ANY PRUDENTIAL AFFILIATE SHALL BE OBLIGATED TO MAKE OR ACCEPT OFFERS TO PURCHASE SHELF NOTES, OR TO QUOTE RATES, SPREADS OR OTHER TERMS WITH RESPECT TO SPECIFIC
PURCHASE OF SHELF NOTES, AND THE FACILITY SHALL IN NO WAY BE CONSTRUED AS A COMMITMENT BY PRUDENTIAL OR ANY PRUDENTIAL AFFILIATE.</B>&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 2.2(i) of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;(a)&nbsp;&nbsp;&nbsp;&nbsp;June 23, 2023 (or if such day is not a Business Day, the Business Day next succeeding such day).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The first sentence of the first paragraph of Section&nbsp;5 of the Note Facility is hereby amended and restated in
its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The Purchasers and the holders of the Notes recognize and acknowledge that the Company may
supplement the following representations and warranties in this Section&nbsp;5, including the Schedules related thereto, pursuant to a Request for Purchase; <U>provided</U> that (i)&nbsp;no such supplement to any representation or warranty
applicable to any particular Closing Day shall change or otherwise modify or be deemed or construed to change or otherwise modify any representation or warranty given on any other Closing Day or any determination of the falseness or inaccuracy
thereof pursuant to Section&nbsp;11(e), and (ii)&nbsp;no supplement to Section&nbsp;5.3 as to any particular Closing Day shall be made after the Company makes a Request for Purchase in respect of such Closing Day.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 5.3 of the Note Facility is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;This Agreement and the documents, certificates or other writings (including the financial
statements described in Section&nbsp;5.5 and the financial statements provided pursuant to the terms hereof) delivered to the Purchasers by or on behalf of the Company in connection with the transactions contemplated hereby (this Agreement and such
documents, certificates or other writings and financial statements delivered to each Purchaser prior to the date of delivery of the applicable Request for Purchase being referred to, collectively, as the &#147;<B>Disclosure Documents</B>&#148;),
taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the
Disclosure Documents, since the end of the most recent fiscal year for which audited financial statements have been furnished there has been no change in the financial condition, operations, business or properties of the Company or any Subsidiary
except changes that individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set
forth herein or in the Disclosure Documents. For the purposes of this Section&nbsp;5.3, the Disclosure Documents shall be deemed to include all filings made with, or furnished to, the Securities and Exchange Commission by the Company pursuant to
sections 13 or 15(d) of the Exchange Act, and the Company shall be deemed to have made delivery of any such Disclosure Document if it shall have timely made such Disclosure Document available on the Securities and Exchange Commission&#146;s
Electronic Data Gathering Analysis, and Retrieval system, or its successor thereto (&#147;<B>EDGAR</B>&#148;). Notwithstanding the foregoing, for purposes of this Section&nbsp;5.3, and only from the First Amendment Effective Date until
December&nbsp;31, 2020, the impacts of the existing Coronavirus pandemic on the business, operations or financial condition of the Company and its Subsidiaries taken as a whole that have occurred and were disclosed in writing to Prudential prior to
the First Amendment Effective Date will be disregarded.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 7.2(a) of the Note Facility is hereby
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenant Compliance</U> &#150; (i)
the information required in order to establish whether the Company was in compliance with the requirements of Section&nbsp;10.9 (including reasonably detailed calculations), (ii) a certification by such Senior Financial Officer (A)&nbsp;that the
Company was in compliance with the requirements of Section&nbsp;10.5(o), Section&nbsp;10.6(a) and (b)(vi) and Section&nbsp;10.7(g)(iii) during the quarterly or annual period covered by the statements then being furnished (including with respect to
each such Section, if requested, the calculations of the maximum or minimum amount, ratio or percentage, as the case may be, permissible under the terms of such Sections, and the calculation of the amount, ratio or percentage then in existence), (B)
as to whether any Subsidiary that is not a Guarantor has executed any Guaranty with respect to any Principal Credit Facility during the relevant period, and (C)&nbsp;that such financial statements have been prepared in accordance with GAAP (subject
in the case of subsection 7.1(b) to normal, recurring, <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and except for the absence of GAAP notes thereto), (iii) a reconciliation of the treatment of leases in the financial statements
accompanying such Officer&#146;s Certificate with the treatment of leases under GAAP as in effect on the date hereof, in form and substance reasonably satisfactory to the Required Holders, and (iv)&nbsp;with respect to the financial statements
delivered pursuant to Section&nbsp;7.1(b), to the extent the Leverage Spike is accruing as of the date of such certificate, a reasonably detailed calculation of the Consolidated Net Leverage Ratio as of the last day of the four consecutive fiscal
quarters of the Company in respect of which such certificate is delivered; and&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.5(j) of the Note Facility is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(j)&nbsp;&nbsp;&nbsp;&nbsp;judgment and other similar Liens arising in
connection with court proceedings in an aggregate amount not in excess of $10,000,000 (except to the extent covered by independent third-party insurance) provided that the execution or other enforcement of such Liens is effectively stayed and the
claims secured thereby are being actively contested in good faith and by appropriate proceedings;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.9 of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>10.9</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consolidated Net Leverage Ratio.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not (i)&nbsp;permit the Consolidated Leverage Ratio at any time during any period
of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending on or before March&nbsp;31, 2020 to exceed 3.25 to 1.00, (ii) permit the Consolidated Net Leverage Ratio at any time during any period of four
consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2020 and on or before March&nbsp;31, 2021 to exceed 3.75 to 1.00 or (iii)&nbsp;subject to Section&nbsp;10.9(c), permit the
Consolidated Leverage Ratio at any time during any period of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2021 to exceed 3.25 to 1.00. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If at any time during the Leverage Spike Period, the Consolidated Net Leverage Ratio exceeds, as of
the last day of any fiscal quarter of the Company, 3.0 to 1.00, the interest rate applicable to the Notes shall increase by 1.00% per annum for the fiscal quarter next succeeding such fiscal quarter (such increase, a &#147;<B>Leverage
Spike</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;(i) If, after March&nbsp;31, 2021, the Company consummates an acquisition
permitted by this Agreement for aggregate cash consideration exceeding $150,000,000 (each, a &#147;<B>Material Acquisition</B>&#148;), the Company may elect, upon written notice to Prudential and each holder of a Note, to increase the maximum
Consolidated Leverage Ratio permitted by Section&nbsp;10.9(a)(iii) to 3.75 to 1.00 for the fiscal quarter in which such Material Acquisition is consummated and the three consecutive fiscal quarters of the Company following such Material Acquisition
(each, a &#147;<B>Four Quarter Period</B>&#148;) (retroactive to the first day of such Four Quarter Period); provided, however, that if the Consolidated Leverage Ratio is equal to or less than 3.25 to 1.00 at the end of any fiscal quarter during the
Four Quarter Period, it may not exceed 3.25 to 1.00 at the end of any subsequent fiscal quarter (regardless of whether such fiscal quarter falls within the Four Quarter Period) unless and until it can and does make another election under this clause
(i). Such notice shall be provided no later than the last Business Day of the fiscal quarter of the Company in which the relevant Material Acquisition is consummated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If the Company makes the election provided for
in Section&nbsp;10.9(c)(i), the interest rate applicable to the Notes shall increase by 0.50% per annum above the rate otherwise prevailing for each fiscal quarter of the Company following a fiscal quarter occurring during the Four Quarter Period at
the end of which the Consolidated Leverage Ratio for the four fiscal quarters of the Company ending with (and including) such fiscal quarter exceeds 3.25 to 1.00 (such increase, an &#147;<B>Acquisition Spike</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The Company may not make the election provided for in Section&nbsp;10.9(c)(i) more than three
times after the Original Closing Date and may not make such election at any time after the first such election unless there has been at least one fiscal quarter of the Company following a Four Quarter Period at the end of which fiscal quarter the
Consolidated Leverage Ratio did not exceed 3.25 to 1.00. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;If an interest payment on any Notes is
due after the last day of any fiscal quarter of the Company, but before the Consolidated Net Leverage Ratio or the Consolidated Leverage Ratio, as the case may be, as of such last day has been calculated, then the Company shall pay an amount
calculated as if the interest rate in effect on such last day had continued thereafter.&nbsp;If such calculation shows that there was a change in the interest rate on the Notes effective as of the first day following such last day, then the amount
of interest payable by the Company on the next succeeding interest payment date in respect of such Notes shall be increased or decreased, as applicable, to the extent necessary to reflect the interest rate that should have been taken into account as
of such first following day.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Section 10 of the Note Facility is hereby amended by adding the following
new Subsection 10.11 to immediately follow Subsection 10.10 therein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Section</B><B></B><B>&nbsp;10.11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Payments.</B> Until the later of
(i)&nbsp;the date of termination of the Leverage Spike Period and (ii)&nbsp;the date that no other Principal Credit Facility has a restriction on the payment of Restricted Payments, the Company will not declare or pay any dividend on, or make any
payment on account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any Equity Interests of the Company (any such dividend, payment or setting apart, a
&#147;<B>Restricted Payment</B>&#148;), whether outstanding on the First Amendment Effective Date or thereafter, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of the
Company or any Subsidiary, except (a)&nbsp;the Company may make Restricted Payments in the form of Equity Interests of the Company and (b)&nbsp;the Company may make Restricted Payments in cash, in lieu of the issuance of fractional shares, upon the
exercise of warrants or upon the conversion or exchange of Equity Interests of the Company.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Section 22
of the Note Facility is hereby amended by adding the following new Subsection 22.11 to immediately follow Subsection 22.10 therein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Section</B><B></B><B>&nbsp;22.11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B></B><B>Divisions</B>. For all purposes under the
Financing Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#146;s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset,
right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b)&nbsp;if any new Person comes into existence, such new Person shall be deemed to have
been organized on the first date of its existence by the holders of Equity Interests at such time.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;Schedule B of the Note Facility is hereby amended by adding the
following new definitions in alphabetical order: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">364-Day</FONT> Credit
Facility</B>&#148; means the $700,000,000 Credit Agreement dated as of April&nbsp;17, 2020, among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank, National Association, as syndication agent, the lenders party
thereto, and T.D. Bank, N.A., ING Bank, N.V., Dublin Branch, MUFG Bank, Ltd., The Bank of New York Mellon and UniCredit Bank, A.G., as <FONT STYLE="white-space:nowrap">co-documentation</FONT> agents, as the same may be amended, supplemented,
restated or otherwise modified from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquisition Spike</B>&#148; is defined in Section&nbsp;10.9.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Additional Interest</B>&#148; means, at any time, the sum of the Acquisition Spike (if any) and the Leverage
Spike (if any) at such time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash Equivalents</B>&#148; means as of any date, (a)&nbsp;securities issued or
directly and fully guaranteed or insured by the U.S. government or any agency or instrumentality thereof having maturities of not more than one year from such date rated at least <FONT STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof
by S&amp;P or A3 or the equivalent thereof by Moody&#146;s, (b)&nbsp;time deposits and certificates of deposits having maturities of not more than one year from such date and issued by any domestic commercial bank having (i)&nbsp;senior long term
unsecured debt rated at least <FONT STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof by S&amp;P or A3 or the equivalent thereof by Moody&#146;s and (ii)&nbsp;capital surplus in excess of $100,000,000, (c) commercial paper rated at
least <FONT STYLE="white-space:nowrap">A-2</FONT> or the equivalent thereof by S&amp;P or <FONT STYLE="white-space:nowrap">P-2</FONT> or the equivalent thereof by Moody&#146;s and in either case maturing within 120 days from such date and
(d)&nbsp;shares of any money market mutual fund rated at least <FONT STYLE="white-space:nowrap">AA-</FONT> or the equivalent thereof by S&amp;P or at least Aa3 or the equivalent thereof by Moody&#146;s. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net Debt</B>&#148; means, at any date of determination, (a)&nbsp;Consolidated Total Debt at such date
minus (b)&nbsp;Unrestricted Cash at such date in an aggregate amount not to exceed $250,000,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net
Leverage Ratio</B>&#148; means, at any date of determination, the ratio of (a)&nbsp;Consolidated Net Debt on such date to (b)&nbsp;Consolidated EBITDA for the period of the four fiscal quarters ending on (or most recently ended prior to) such date.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cost Savings</B>&#148; means reductions in salary expenses, benefit expenses and other related expenses of the
Company resulting from a reduction in its workforce which are reasonably determined by the Company in good faith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Designated Charges</B>&#148; means, for any period, subject to the
last two sentences of this definition, the sum of (a)&nbsp;to the extent deducted in computing Consolidated Operating Income for such period, the aggregate of total (i)&nbsp;extraordinary, unusual or
<FONT STYLE="white-space:nowrap">non-recurring</FONT> charges and expenses and (ii)&nbsp;Restructuring Expenses plus (b)&nbsp;Pro Forma Cost Savings for such period. The sum of Restructuring Expenses and Pro Forma Cost Savings for any period shall
not exceed (1)&nbsp;in the case of any such period ending on or prior to December&nbsp;31, 2019, 10% of Consolidated EBITDA for such period, (2)&nbsp;in the case of any such period ending after December&nbsp;31, 2019 and on or prior to
March&nbsp;31, 2021, $100,000,000 and (3)&nbsp;in the case of any such period ending after March&nbsp;31, 2021, 10% of Consolidated EBITDA for such period; Restructuring Expenses and Pro Forma Cost Savings shall be determined on a consolidated basis
in accordance with GAAP and calculated consistently with the Company&#146;s calculation thereof in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. The aggregate amount of Pro
Forma Cost Savings for any period of four fiscal quarters ending after March&nbsp;31, 2020 and on or prior to March&nbsp;31, 2021 shall not exceed $25,000,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>First Amendment</B>&#148; means that certain Fist Amendment to Second Amended and Restated Multicurrency Private Shelf
Agreement, dated as of June&nbsp;23, 2020, among the Company, Prudential and each holder party thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>First
Amendment Effective Date</B>&#148; has the definition set forth in the First Amendment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike</B>&#148;
is defined in Section&nbsp;10.9. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike Period</B>&#148; means the period commencing on the First
Amendment Effective Date and ending on (and including) the first date on which the Company delivers evidence to the holders of Notes that (i)&nbsp;the Consolidated Leverage Ratio is less than or equal to 3.25 to 1.00 for a period of four consecutive
fiscal quarters of the Company ending on or after June&nbsp;30, 2021 and (ii)&nbsp;no Event of Default has occurred or is continuing on such date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moodys</B>&#148; means Moody&#146;s Investors Service, Inc., or any successor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Pro Forma Cost Savings</B>&#148; means (a)&nbsp;in respect of the four quarters of the Company ending on June&nbsp;30,
2020, the Cost Savings attributable to the fiscal quarter of the Company ending on such date multiplied by three, (b)&nbsp;in respect of the four quarters of the Company ending on September&nbsp;30, 2020, an amount equal to the Cost Savings
attributable to the period of two consecutive fiscal quarters of the Company ending on such date, (c)&nbsp;in respect of the four quarters of the Company ending on December&nbsp;31, 2020, the Cost Savings attributable to the period of three
consecutive fiscal quarters of the Company ending on such date multiplied by one third and (d)&nbsp;at all times thereafter, zero. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Payment</B>&#148; is defined in Section&nbsp;10.11. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restructuring Expenses</B>&#148; means restructuring, consolidation, transaction, integration or other similar charges
and expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings
Services, a division of The McGraw-Hill Company, or its successors or assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unrestricted Cash</B>&#148; means,
as at any date of determination, the aggregate amount of cash and Cash Equivalents included in the cash accounts that would be listed on the consolidated balance sheet of the Company and its Subsidiaries, determined on such date on a consolidated
basis in accordance with GAAP and as calculated consistent with the manner disclosed by the Company in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016, to the extent such cash
and Cash Equivalents are not (a)&nbsp;subject to a Lien securing any Indebtedness or other obligations or (b)&nbsp;classified as &#147;restricted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Consolidated EBITDA</B>&#148; in Schedule B of the Note Facility is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated EBITDA</B>&#148; means, for any period, Consolidated Operating
Income plus, without duplication, (a)&nbsp;Consolidated Interest Income, (b)&nbsp;depreciation, (c) amortization, (d)&nbsp;the Designated Charges and (e)&nbsp;to the extent deducted in computing Consolidated Operating Income, stock-based
compensation of the Company and its Subsidiaries in each case for such period and determined on a consolidated basis in accordance with GAAP and, except for Designated Charges consisting of Pro Forma Cost Savings, as calculated consistent with the
manner disclosed by the Company in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Covenant Reset Date</B>&#148; in Schedule B of the Note Facility is hereby deleted in
its entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Existing Credit Facility</B>&#148; in Schedule B of the Note Facility
is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Existing Credit Facility</B>&#148; means the
$750,000,000 Credit Agreement, dated as of April&nbsp;18, 2017 (as amended by the First Amendment dated as of June&nbsp;29, 2018, and as further amended by the Second Amendment dated as of April&nbsp;17, 2020), among the Company, as borrower,
JPMorgan Chase Bank, N.A., as administrative agent, the syndication agent, the lenders party thereto and JPMorgan Chase Bank, N.A. and U.S. Bank National Association, as joint lead arrangers and joint bookrunners, as the same may be amended,
supplemented, restated or otherwise modified from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Principal Credit
Facility</B>&#148; in Schedule B of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Principal Credit Facility</B>&#148; means any agreement, instrument or facility, and any renewal, refinancing,
refunding or replacement thereof, or any two or more of any of the foregoing forming part of a common interrelated financing or other transaction (collectively, a &#147;<B>Credit Agreement</B>&#148;) in respect of which the Company or any Subsidiary
is a borrower, guarantor or other obligor, providing for the incurrence of Indebtedness by the Company or any Subsidiary in an aggregate principal amount equal to or in excess of $200,000,000 (or the equivalent thereof in any other currency),
regardless of the principal amount outstanding thereunder from time to time. For the avoidance of doubt, each of the Existing Credit Facility, the <FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility, the Existing Note Agreement, the New
York Life Shelf Agreement and the MetLife Shelf Agreement is a Principal Credit Facility. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits 1.3(a), 1.3(b), 1.3(c), 1.3(d), 1.3(e), 1.3(f), 1.4 and
9.8 of the Note Facility are hereby amended to delete the reference to &#147;Acquisition Spike&#148; therein, and to insert in lieu thereof &#147;Additional Interest&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Restatement of Existing Notes</U>. Subject to the satisfaction of the conditions
precedent set forth in <U>Section</U><U></U><U>&nbsp;5</U> hereof, the Existing Notes are hereby, automatically and without any further action, amended and restated in their entirety to delete the reference to &#147;Acquisition Spike&#148; therein
and to reflect in lieu thereof &#147;Additional Interest&#148;. The parties hereto hereby acknowledge and agree that the amendments to the Existing Notes set forth herein could have been effected through an agreement or instrument of amendment, and
for convenience, the parties hereto have agreed to restate the terms and provisions of the Existing Notes, as amended hereby, pursuant to this <U>Section</U><U></U><U>&nbsp;3</U>. At the request of any Holder, the Company shall execute and deliver a
new Note or Notes in the form of the relevant Exhibit (as amended by this Amendment) to the Note Facility, in exchange for, and in replacement of, each Holder&#146;s Existing Note, within five Business Days of such request, registered in the name of
such Holder, in the aggregate outstanding principal amount of such Existing Note and dated as of the last interest payment date of such Existing Note. Any Notes issued on or after the First Amendment Effective Date shall be in the form of the
relevant Exhibit to the Note Facility, as amended by this Amendment. The parties hereto specifically agree and confirm that the transactions effected hereby and by the Notes shall in no way evidence a new debt of the Company or a novation of the
Existing Notes, but rather that all outstanding debt of the Company in respect of the Existing Notes is continued in full force and effect on the terms and conditions set forth in the Note Facility and the Notes (in each case as modified by this
Amendment). All outstanding amounts owing by the Company in respect of the Existing Notes shall continue to be owing under the Note Facility and the Notes (without any further action required on the part of any Person), and shall be payable in
accordance with the Note Facility and the Notes (in each case as modified by this Amendment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. To induce Prudential and the Holders to enter into this
Amendment, the Company hereby represents and warrants to Prudential and the Holders that, both before (except with respect to Section&nbsp;4(c) below) and after giving effect to this Amendment: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and performance by the Company of this Amendment (i)&nbsp;are within the Company&#146;s
requisite corporate or other applicable power and authority; (ii)&nbsp;have been duly authorized by all necessary corporate action; (iii)&nbsp;will not violate any Requirement of Law or Contractual Obligation of the Company or any if its
Subsidiaries, except for such violations of Contractual Obligations which, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect; (iv)&nbsp;will not result in, or require, the creation or imposition of
any Lien on any of its or their respective properties or revenues pursuant to any such Requirement of Law or Contractual Obligation which, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect; and
(v)&nbsp;will not require any consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person with respect to the Company or any of its Restricted Subsidiaries except for such
consents, authorizations, filings, notices or other acts relating to such other Person which, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment has been duly executed and delivered on behalf of
the Company. This Amendment constitutes and, upon execution and delivery thereof, will constitute, a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the effects of
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors&#146; rights generally, general equitable principles (whether considered in a proceeding in equity or at law) and an
implied covenant of good faith and fair dealing; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;After giving effect to this Amendment, the
representations and warranties contained in the Note Facility (except with respect to Section&nbsp;5.8 of the Note Facility, as disclosed in the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or in the
Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> in each case, most recently filed with the Securities and Exchange Commission) and the other Financing<B> </B>Documents are true and correct in all material respects
as of the First Amendment Effective Date except to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment and the documents, certificates or other writings delivered to the Holders by or on behalf of the
Company in connection with the amendments set forth herein, taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the
circumstances under which they were made. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the other documents, certificates or other writings
delivered to Prudential or the Holders by or on behalf of the Company in connection with the amendments set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;No event has occurred and no condition exists that, either before or after giving effect to this Amendment,
constitutes or would constitute a Default or an Event of Default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not paid, nor has it agreed
to pay, any fees or other compensation in connection with the amendments described in clauses (b), (c) and (d)&nbsp;of Section&nbsp;5 below, apart from an amendment fee equal to .10% of the principal amount of notes outstanding (i)&nbsp;under the
MetLife Shelf Agreement in connection with the MetLife Amendment (as hereinafter defined), and (ii)&nbsp;under the New York Life Shelf Agreement in connection with the New York Life Amendment (as hereinafter defined). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Effectiveness</U>. The amendments set forth in <U>Section</U><U></U><U>&nbsp;2</U> of
this Amendment and the amendment and restatement of the Existing Notes set forth in <U>Section</U><U></U><U>&nbsp;3</U> of this Amendment shall become effective on the first date on which the following conditions precedent have been satisfied or
waived (the first date on which such conditions shall have been so satisfied or waived, the &#147;<U>First Amendment Effective Date</U>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company, Prudential and the Holders shall have executed and delivered a counterpart of this Amendment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Prudential shall have received a fully executed copy of an
amendment agreement to the Existing Credit Facility, dated as of April&nbsp;17, 2020, by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto, in form and substance satisfactory to the Required
Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Prudential shall have received a fully executed copy of an amendment agreement to the New York Life
Shelf Agreement, dated as of the date hereof (the &#147;<U>New York Life Amendment</U>&#148;), by and among the Company, NYL Investors LLC and the other holders of notes party thereto, in form and substance satisfactory to the Required Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Prudential shall have received a fully executed copy of an amendment agreement to the MetLife Shelf Agreement,
dated as of the date hereof (the &#147;<U>MetLife Amendment</U>&#148;), by and among the Company, Metropolitan Life Insurance Company and MetLife Investment Advisors Company, LLC and the other holders of notes party thereto, in form and substance
satisfactory to the Required Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Prudential and the Holders shall have received a certificate signed by a
Responsible Officer of the Company certifying that the conditions specified in clauses (f)&nbsp;and (g) of this <U>Section</U><U></U><U>&nbsp;5</U> has been satisfied as of the First Amendment Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Each of the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4</U> above shall be true and
correct in all material respects on and as of the First Amendment Effective Date as if made on and as of such date (or, if any such representation and warranty is expressly stated to have been made as of a specific date, as of such specific date).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default shall have occurred and be continuing on and as of the First Amendment
Effective Date or immediately after giving effect to this Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Prudential and the Holders shall have
received a certificate from the Secretary of the Company, in form and substance satisfactory to the Holders, dated as of the date hereof (i)&nbsp;attaching and certifying as to copies of corporate resolutions of the Company relating to the
authorization, execution and delivery, as applicable, of this Amendment and any other documents to be entered into in connection herewith, (ii)&nbsp;attaching and certifying as to copies of its organizational documents as then in effect and
(iii)&nbsp;certifying as to the signatures and incumbency of relevant officers of the Company executing this Amendment and any other documents to be entered into in connection herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Prudential and the Holders shall have received a good standing certificate for the Company from the Secretary of
State of Delaware, dated as of a recent date, and such other evidence of the status of the Company as Prudential and the Holders may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder shall have received payment of an amendment fee of 10 basis points (0.10%) of the principal amount of
the Notes held by such Holder outstanding on the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have paid the reasonable fees and disbursements
of the Holders&#146; special counsel in accordance with <U>Section</U><U></U><U>&nbsp;7</U> below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effects on Note Facility</U>. This Amendment shall be construed in connection with and as a part of
the Note Facility and, except as specifically amended herein, the Note Facility shall continue to be in full force and effect and is hereby in all respects ratified and confirmed. Any and all notices, requests, certificates and other instruments
executed and delivered after the execution and delivery of this Amendment may refer to the Note Facility without making specific reference to this Amendment, but nevertheless all such references shall include this Amendment unless the context
otherwise requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Without prejudice to the provisions of Section&nbsp;15
(<I>Expenses, Etc.</I>) of the Note Facility, whether or not the amendments set forth herein become effective, the Company agrees to pay or reimburse Prudential and the Holders for all of their reasonable and invoiced
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the development, preparation and execution of this Amendment and any other documents prepared in connection
herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including, without limitation, the reasonble and documented fees and disbursements of Akin Gump Strauss Hauer&nbsp;&amp; Feld LLP,
counsel to Prudential and the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;<U>GOVERNING LAW; WAIVER OF JURY TRIAL</U>. THIS AMENDMENT
SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK EXCLUDING
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">CHOICE-OF-LAW</FONT></FONT> PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. EACH PARTY HERETO HEREBY AGREES
AS SET FORTH FURTHER IN SECTION 22.8 OF THE NOTE FACILITY AS IF SUCH SECTION WAS SET FORTH IN FULL HEREIN. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Novation</U>. This Amendment is not intended by the parties to be, and shall not be construed to
be, a novation of the Note Facility or an accord and satisfaction in regard thereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing
Document</U>. This Amendment shall constitute a &#147;Financing Document&#148; for all purposes of the Note Facility and the other Financing Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments; Execution in Counterparts; Electronic Execution</U>. This Amendment shall not
constitute an amendment of any other provision of the Note Facility not referred to herein and shall not be construed as a waiver or consent to any further or future action on the part of the Company that would require a waiver or consent of the
Holders or Prudential. Except as expressly amended hereby, the provisions of the Note Facility are and shall remain in full force and effect. This Amendment may be executed in any number of counterparts and by the different parties hereto on
separate counterparts, including by means of facsimile or electronic transmission, each of which when so executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delivery of an executed counterpart of a signature page of this Amendment by telecopy,
emailed pdf. or any other electronic means that reproduces an image of the actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment. The words &#147;execution,&#148; &#147;signed,&#148;
&#147;signature,&#148; &#147;delivery,&#148; and words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include an electronic sound, symbol, or
process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record (each an &#147;<U>Electronic Signature</U>&#148;), each of which shall be of the same
legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal
Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that nothing herein shall require
Prudential or the Holders to accept Electronic Signatures in any form or format without their prior written consent. Without limiting the generality of the foregoing, each party hereto hereby (i)&nbsp;agrees that, for all purposes, including without
limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Prudential, the Company and the other parties hereto, electronic images of this Amendment or any other Financing
Documents (in each case, including with respect to any signature pages thereto) shall have the same legal effect, validity and enforceability as any paper original, and (ii)&nbsp;waives any argument, defense or right to contest the validity or
enforceability of this Amendment or any of the other Financing Documents based solely on the lack of paper original copies of this Amendment or any other Financing Documents, including with respect to any signature pages hereto or thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. All covenants and other agreements contained in this Amendment by or on
behalf of any of the parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Note) whether so expressed or not. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Any provision of this Amendment that is prohibited or unenforceable in any
jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall (to the
full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I></I>[<I>Remainder of
page intentionally left blank</I>]<I> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective proper and duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HENRY SCHEIN, INC.,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">as the Company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">by</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Amodio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael Amodio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PGIM, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">THE PRUDENTIAL INSURANCE COMPANY OF AMERICA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">THE GIBRALTAR LIFE INSURANCE CO., LTD</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: Prudential Investment Management Japan Co., Ltd., as Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM, Inc. (as <FONT STYLE="white-space:nowrap">Sub-Adviser)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM, Inc., as investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PRUDENTIAL ARIZONA REINSURANCE UNIVERSAL COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM, Inc., as investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">THE PRUDENTIAL LIFE INSURANCE COMPANY, LTD.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: Prudential Investment Management Japan Co., Ltd., as Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM, Inc. (as <FONT STYLE="white-space:nowrap">Sub-Adviser)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PRUDENTIAL ARIZONA REINSURANCE TERM COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM, Inc., as investment manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">BCBSM, INC. DBA BLUE CROSS AND BLUE SHIELD OF MINNESOTA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">FARMERS NEW WORLD LIFE INSURANCE COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MEDICA HEALTH PLANS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">THE INDEPENDENT ORDER OF FORESTERS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By: PGIM Private Placement Investors, Inc. (as its</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">General Partner)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">FARMERS INSURANCE EXCHANGE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MID CENTURY INSURANCE COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">PHYSICIANS MUTUAL INSURANCE COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ZURICH AMERICAN INSURANCE COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, L.P. (as Investment Advisor)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: PGIM Private Placement Investors, Inc. (as its General Partner)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Seward</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Eric Seward</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (</I><I>Prudential</I><I>)]</I> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d948426dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FIRST
AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE FACILITY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This FIRST AMENDMENT TO SECOND AMENDED AND RESTATED MASTER NOTE
FACILITY, dated as of June&nbsp;23, 2020 (this &#147;<U>Amendment</U>&#148;), is among Henry Schein, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), NYL Investors LLC (as successor in interest to New York Life Investment Management
LLC), a Delaware limited liability company (&#147;<U>New York Life</U>&#148;), as purchaser, and the other financial institution and other entities party hereto that constitute each of the holders of the Notes outstanding as of the date hereof (the
&#147;<U>Holders</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W I T N E S S E T H </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, reference is made to that certain $300,000,000 Second Amended and Restated Master Note Facility, dated as of June&nbsp;29, 2018, by
and among the Company, New York Life and each Holder party thereto (as amended, restated, modified, or supplemented from time to time, the &#147;<U>Note Facility</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has requested that the Note Facility be amended by this Amendment in order to, among other things, (i)&nbsp;extend the
Issuance Period and (ii)&nbsp;effect certain changes to the covenant set forth in Section&nbsp;10.1 of the Note Facility; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Company, New York Life and the Holders are willing to enter into such amendments subject and pursuant to the terms and conditions of this Amendment; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and mutual covenants contained herein, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined Terms</U>. Unless otherwise defined herein, capitalized terms used but not defined herein
shall have the meanings assigned to such terms in the Note Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment to the Note
Facility</U>. Effective as of the First Amendment Effective Date, the Note Facility is hereby amended as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 2.2(a) of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;(a)&nbsp;&nbsp;&nbsp;&nbsp;June 23, 2023 (or if such day is not a Business Day, the Business Day next succeeding such day);&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The first sentence of the first paragraph of Section&nbsp;5 of the Note Facility is hereby amended and restated in
its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The Purchasers and the holders of the Notes recognize and acknowledge that the Company may
supplement the following representations and warranties in this Section&nbsp;5, including the Schedules related thereto, pursuant to a Request for Purchase; provided that (i)&nbsp;no such supplement to any representation or warranty applicable to
any particular Closing Date shall change or otherwise modify or be deemed or construed to change or otherwise modify any representation or warranty given on any other Closing Date or any determination of the falseness or inaccuracy thereof pursuant
to Section&nbsp;11(b), and (ii)&nbsp;no supplement to Section&nbsp;5.2 as to any particular Closing Date shall be made after the Company makes a Request for Purchase in respect of such Closing Date.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 5.2 of the Note Facility is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;This Agreement and the documents, certificates or other writings (including the financial
statements described in Section&nbsp;5.1 and the financial statements provided pursuant to the terms hereof) delivered to the Purchasers by or on behalf of the Company in connection with the transactions contemplated hereby (this Agreement and such
documents, certificates or other writings and financial statements delivered to each Purchaser prior to the date of delivery of the applicable Request for Purchase being referred to, collectively, as the &#147;<B>Disclosure Documents</B>&#148;),
taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the
Disclosure Documents, since the end of the most recent fiscal year for which audited financial statements have been furnished there has been no change in the financial condition, operations, business or properties of the Company or any Subsidiary
except changes that individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set
forth herein or in the Disclosure Documents. For the purposes of this Section&nbsp;5.2, the Disclosure Documents shall be deemed to include all filings made with, or furnished to, the Securities and Exchange Commission by the Company pursuant to
sections 13 or 15(d) of the Exchange Act, and the Company shall be deemed to have made delivery of any such Disclosure Document if it shall have timely made such Disclosure Document available on the Securities and Exchange Commission&#146;s
Electronic Data Gathering Analysis, and Retrieval system, or its successor thereto (&#147;<B>EDGAR</B>&#148;). Notwithstanding the foregoing, for purposes of this Section&nbsp;5.2, and only from the First Amendment Effective Date until
December&nbsp;31, 2020, the impacts of the existing Coronavirus pandemic on the business, operations or financial condition of the Company and its Subsidiaries taken as a whole that have occurred and were disclosed in writing to New York Life prior
to the First Amendment Effective Date will be disregarded.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 7.2(a) of the Note Facility is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(a)&nbsp;simultaneously with the delivery of the financial statements referred
to in subsections 7.1(a) and (b), a certificate of the chief financial officer or treasurer of the Company, (i)&nbsp;certifying that to the best of his knowledge (A)&nbsp;no Default or Event of Default has occurred and is continuing or, if a Default
or Event of Default has occurred and is continuing, a statement as to the nature thereof and the action which is proposed to be taken with respect thereto, (B)&nbsp;the Company is in compliance with the requirements of subsections 10.1 (including
reasonably detailed calculations), 10.2(p), 10.3(a), 10.3(b)(viii) and 10.5(g) (and including with respect to each such subsection, if requested, the calculations of the maximum or minimum amount, ratio or percentage, as the case may be, permissible
under the terms of such subsections, and the calculation of the amount, ratio or percentage then in existence), (C) whether any Subsidiary that is not a Guarantor has executed any Guaranty with respect to any Principal Debt Facility during the
relevant period, and (D)&nbsp;such financial statements have been prepared in accordance with GAAP (subject in the case of subsection 7.1(b) to normal, recurring, <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and except for the
absence of GAAP notes thereto), (ii) setting forth a reconciliation of the treatment of leases which are or would be deemed by GAAP as in effect on the date hereof to be treated as operating leases, in form and substance reasonably satisfactory to
the Required Holders and (iii)&nbsp;with respect to the financial statements delivered pursuant to Section&nbsp;7.1(b), to the extent the Leverage Spike is accruing as of the date of such certificate, a reasonably detailed calculation of the
Consolidated Net Leverage Ratio as of the last day of the four consecutive fiscal quarters of the Company in respect of which such certificate is delivered;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.1 of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>10.1</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Consolidated Net Leverage Ratio.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not (i)&nbsp;permit the Consolidated Leverage Ratio at any time during any period
of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending on or before March&nbsp;31, 2020, to exceed 3.25 to 1.0, (ii) permit the Consolidated Net Leverage Ratio at any time during any period of four
consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2020 and on or before March&nbsp;31, 2021 to exceed 3.75 to 1.0 or (iii)&nbsp;subject to Section&nbsp;10.1(c), permit the
Consolidated Leverage Ratio at any time during any period of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2021 to exceed 3.25 to 1.0. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If at any time during the Leverage Spike Period, the Consolidated Net Leverage Ratio exceeds, as of
the last day of any fiscal quarter of the Company, 3.00 to 1.0, the interest rate applicable to the Notes shall increase by 1.00% per annum for the fiscal quarter next succeeding such fiscal quarter (such increase, a &#147;<B>Leverage
Spike</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;(i) If, after March&nbsp;31, 2021, the Company consummates an acquisition
permitted by this Agreement for aggregate cash consideration exceeding $150,000,000 (each, a &#147;<B>Material Acquisition</B>&#148;), the Company may elect, upon written notice to New York Life and each holder of a Note, to increase the maximum
Consolidated Leverage Ratio permitted by Section&nbsp;10.1(a)(iii) to 3.75 to 1.0 for the fiscal quarter in which such Material Acquisition is consummated and the three consecutive fiscal quarters of the Company following such Material Acquisition
(each, a &#147;<B>Four Quarter Period</B>&#148;) (retroactive to the first day of such Four Quarter Period); provided, however, that if the Consolidated Leverage Ratio is equal to or less than 3.25 to 1.0 at the end of any fiscal quarter during the
Four Quarter Period, it may not exceed 3.25 to 1.0 at the end of any subsequent fiscal quarter (regardless of whether such fiscal quarter falls within the Four Quarter Period) unless and until it can and does make another election under this clause
(i). Such notice shall be provided no later than the last Business Day of the fiscal quarter of the Company in which the relevant Material Acquisition is consummated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If the Company makes the election provided for
in Section&nbsp;10.1(c)(i), the interest rate applicable to the Notes shall increase by 0.50% per annum above the rate otherwise prevailing for each fiscal quarter of the Company following a fiscal quarter occurring during the Four Quarter Period at
the end of which the Consolidated Leverage Ratio for the four fiscal quarters of the Company ending with (and including) such fiscal quarter exceeds 3.25 to 1.0 (such increase, an &#147;<B>Acquisition Spike</B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The Company may not make the election provided for in Section&nbsp;10.1(c)(i) more than three
times after the Original Closing Date and may not make such election at any time after the first such election unless there has been at least one fiscal quarter of the Company following a Four Quarter Period at the end of which fiscal quarter the
Consolidated Leverage Ratio did not exceed 3.25 to 1.0. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;If an interest payment on any Notes is
due after the last day of any fiscal quarter of the Company, but before the Consolidated Net Leverage Ratio or the Consolidated Leverage Ratio, as the case may be, as of such last day has been calculated, then the Company shall pay an amount
calculated as if the interest rate in effect on such last day had continued thereafter.&nbsp;If such calculation shows that there was a change in the interest rate on the Notes effective as of the first day following such last day, then the amount
of interest payable by the Company on the next succeeding interest payment date in respect of such Notes shall be increased or decreased, as applicable, to the extent necessary to reflect the interest rate that should have been taken into account as
of such first following day.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.2(j) of the Note Facility is hereby amended and restated in
its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(j) judgment and other similar Liens arising in connection with court proceedings in an
aggregate amount not in excess of $10,000,000 (except to the extent covered by independent third-party insurance) provided that the execution or other enforcement of such Liens is effectively stayed and the claims secured thereby are being actively
contested in good faith and by appropriate proceedings;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Section 10 of the Note Facility is hereby
amended by adding the following new Subsection 10.12: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>Section</B><B></B><B>&nbsp;10.12.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>
Restricted Payments</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the later of (i)&nbsp;the date of termination of the Leverage Spike Period and
(ii)&nbsp;the date that no other Principal Credit Facility has a restriction on the payment of Restricted Payments, the Company will not declare or pay any dividend on, or make any payment on account of, or set apart assets for a sinking or other
analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any Equity Interests of the Company (any such dividend, payment or setting apart, a &#147;<B>Restricted Payment</B>&#148;), whether outstanding on the
First Amendment Effective Date or thereafter, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of the Company or any Subsidiary, except (a)&nbsp;the Company may make
Restricted Payments in the form of Equity Interests of the Company and (b)&nbsp;the Company may make Restricted Payments in cash, in lieu of the issuance of fractional shares, upon the exercise of warrants or upon the conversion or exchange of
Equity Interests of the Company.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Section 22 of the Note Facility is hereby amended by adding the
following new Subsection 22.11: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>&#147;Section</B><B></B><B>&nbsp;22.11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B></B><B>Divisions</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all purposes under the Note Documents, in connection with any division or plan of division under Delaware law (or any
comparable event under a different jurisdiction&#146;s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred
from the original Person to the subsequent Person, and (b)&nbsp;if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of Equity Interests at such time.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Schedule A of the Note Facility is hereby amended by adding the following new definitions in alphabetical
order: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility</B>&#148; means the $700,000,000 Credit Agreement dated as
of April&nbsp;17, 2020, among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank, National Association, as syndication agent, the lenders party thereto, and T.D. Bank, N.A., ING Bank, N.V., Dublin Branch, MUFG
Bank, Ltd., The Bank of New York Mellon and UniCredit Bank, A.G., as <FONT STYLE="white-space:nowrap">co-documentation</FONT> agents, as the same may be amended, supplemented, restated or otherwise modified from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Additional Interest</B>&#148; means, at any time, the sum of the Acquisition Spike (if any) and the Leverage Spike (if any) at such
time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash Equivalents</B>&#148; means as of any date, (a)&nbsp;securities issued or directly and fully guaranteed or insured by
the U.S. government or any agency or instrumentality thereof having maturities of not more than one year from such date rated at least <FONT STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof by S&amp;P or A3 or the equivalent thereof by
Moody&#146;s, (b)&nbsp;time deposits and certificates of deposits having maturities of not more than one year from such date and issued by any domestic commercial bank having (i)&nbsp;senior long term unsecured debt rated at least <FONT
STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof by S&amp;P or A3 or the equivalent thereof by Moody&#146;s and (ii)&nbsp;capital surplus in excess of $100,000,000, (c) commercial paper rated at least
<FONT STYLE="white-space:nowrap">A-2</FONT> or the equivalent thereof by S&amp;P or <FONT STYLE="white-space:nowrap">P-2</FONT> or the equivalent thereof by Moody&#146;s and in either case maturing within 120 days from such date and (d)&nbsp;shares
of any money market mutual fund rated at least <FONT STYLE="white-space:nowrap">AA-</FONT> or the equivalent thereof by S&amp;P or at least Aa3 or the equivalent thereof by Moody&#146;s. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net Debt</B>&#148; means, at any date of determination,
(a)&nbsp;Consolidated Total Debt at such date minus (b)&nbsp;Unrestricted Cash at such date in an aggregate amount not to exceed $250,000,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net Leverage Ratio</B>&#148; means at any date of determination, the ratio of (a)&nbsp;Consolidated Net Debt on such date
to (b)&nbsp;Consolidated EBITDA for the period of the four fiscal quarters ending on (or most recently ended prior to) such date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cost Savings</B>&#148; means reductions in salary expenses, benefit expenses and other related expenses of the Company resulting from
a reduction in its workforce and are reasonably determined by the Company in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Designated Charges</B>&#148; means, for
any period, subject to the last two sentences of this definition, the sum of (a)&nbsp;to the extent deducted in computing Consolidated Operating Income for such period, the aggregate of total (i)&nbsp;extraordinary, unusual or <FONT
STYLE="white-space:nowrap">non-recurring</FONT> charges and expenses and (ii)&nbsp;Restructuring Expenses plus (b)&nbsp;Pro Forma Cost Savings for such period. The sum of Restructuring Expenses and Pro Forma Cost Savings for any period shall not
exceed (1)&nbsp;in the case of any such period ending on or prior to December&nbsp;31, 2019, 10% of Consolidated EBITDA for such period, (2)&nbsp;in the case of any such period ending after December&nbsp;31, 2019 and on or prior to March&nbsp;31,
2021, $100,000,000 and (3)&nbsp;in the case of any such period ending after March&nbsp;31, 2021, 10% of Consolidated EBITDA for such period; Restructuring Expenses and Pro Forma Cost Savings shall be determined on a consolidated basis in accordance
with GAAP and calculated consistently with the Company&#146;s calculation thereof in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. The aggregate amount of Pro Forma Cost
Savings for any period of four fiscal quarters ending after March&nbsp;31, 2020 and on or prior to March&nbsp;31, 2021 shall not exceed $25,000,000. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>First Amendment</B>&#148; means that certain First Amendment to Second Amended and Restated Master Note Facility, dated as of
June&nbsp;23, 2023, among the Company, New York Life and each holder party thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>First Amendment Effective Date</B>&#148; has
the definition set forth in the First Amendment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike</B>&#148; is defined in Section&nbsp;10.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike Period</B>&#148; means the period commencing on the First Amendment Effective Date and ending on (and including) the
first date on which the Company delivers evidence to the holders of Notes that (i)&nbsp;the Consolidated Leverage Ratio is less than or equal to 3.25 to 1.00 for a period of four consecutive fiscal quarters of the Company ending on or after
June&nbsp;30, 2021 and (ii)&nbsp;no Event of Default has occurred or is continuing on such date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means
Moody&#146;s Investors Service, Inc., or any successor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Pro Forma Cost Savings</B>&#148; means (a)&nbsp;in respect of the four quarters of
the Company ending on June&nbsp;30, 2020 the Cost Savings attributable to the fiscal quarter of the Company ending on such date multiplied by three, (b)&nbsp;in respect of the four quarters of the Company ending on September&nbsp;30, 2020 an amount
equal to the Cost Savings attributable to the period of two consecutive fiscal quarters of the Company ending on such date, (c)&nbsp;in respect of the four quarters of the Company ending on December&nbsp;31, 2020 the Cost Savings attributable to the
period of three consecutive fiscal quarters of the Company ending on such date multiplied by one third and (d)&nbsp;zero thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Payment</B>&#148; is defined in Section&nbsp;10.12. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restructuring Expenses</B>&#148; means restructuring, consolidation, transaction, integration or other similar charges and expenses.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services, a division of The McGraw-Hill Company, or its
successors or assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unrestricted Cash</B>&#148; means as at any date of determination, the aggregate amount of cash and Cash
Equivalents included in the cash accounts that would be listed on the consolidated balance sheet of the Company and its Subsidiaries, determined on such date on a consolidated basis in accordance with GAAP and as calculated consistent with the
manner disclosed by the Company in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016, to the extent such cash and Cash Equivalents are not (a)&nbsp;subject to a Lien securing any
Indebtedness or other obligations or (b)&nbsp;classified as &#147;restricted.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;The definition of
&#147;<B>Consolidated EBITDA</B>&#148; in Schedule A of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated EBITDA</B>&#148; means for any period, Consolidated Operating Income plus, without duplication, (a)&nbsp;Consolidated
Interest Income, (b)&nbsp;depreciation, (c) amortization, (d)&nbsp;the Designated Charges and (e)&nbsp;to the extent deducted in computing Consolidated Operating Income, stock-based compensation of the Company and its Subsidiaries in each case for
such period and determined on a consolidated basis in accordance with GAAP and, except for Designated Charges consisting of Pro Forma Cost Savings, as calculated consistent with the manner disclosed by the Company in its Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The definition
of &#147;<B>Existing Credit Facility</B>&#148; in Schedule A of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Existing Credit Facility</B>&#148; means the $750,000,000 Credit Agreement, dated as of April&nbsp;18, 2017 (as amended by the First
Amendment dated as of June&nbsp;29, 2018, and as further amended by the Second Amendment dated as of April&nbsp;17, 2020), among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, the syndication agent, the lenders party
thereto and JPMorgan Chase Bank, N.A. and U.S. Bank National Association, as joint lead arrangers and joint bookrunners, as the same may be amended, supplemented, restated or otherwise modified from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Principal Debt Facility</B>&#148; in
Schedule A of the Note Facility is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Principal Debt Facility</B>&#148;
means any agreement, instrument or facility, and any renewal, refinancing, refunding or replacement thereof, or any two or more of any of the foregoing forming part of a common interrelated financing or other transaction (collectively, a &#147;Debt
Agreement&#148;) in respect of which the Company or any Subsidiary is a borrower, guarantor or other obligor, providing for the incurrence of Indebtedness by the Company or any Subsidiary in an aggregate principal amount equal to or in excess of
$200,000,000 (or the equivalent thereof in any other currency), regardless of the principal amount outstanding thereunder from time to time. For the avoidance of doubt, each of the Existing Credit Facility, the
<FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility, the Existing Note Agreement, the Prudential Shelf Agreement and the MetLife Note Agreement is a Principal Debt Facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits <FONT STYLE="white-space:nowrap">A-1,</FONT> <FONT STYLE="white-space:nowrap">A-2,</FONT> <FONT
STYLE="white-space:nowrap">A-3,</FONT> <FONT STYLE="white-space:nowrap">A-4,</FONT> and <FONT STYLE="white-space:nowrap">A-5</FONT> of the Note Facility are hereby amended to delete the reference to &#147;Acquisition Spike&#148; therein, and to
insert in lieu thereof &#147;Additional Interest&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Restatement of Existing
Notes</U>. Subject to the satisfaction of the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;5</U> hereof, the Series A Notes, the Series B Notes, the Series C Notes and the Series D Notes (collectively, the &#147;<U>Existing
Notes</U>&#148;) are hereby, automatically and without any further action, amended and restated in their entirety to delete the reference to &#147;Acquisition Spike&#148; therein and to reflect in lieu thereof &#147;Additional Interest&#148;. The
parties hereto hereby acknowledge and agree that the amendments to the Existing Notes set forth herein could have been effected through an agreement or instrument of amendment, and for convenience, the parties hereto have agreed to restate the terms
and provisions of the Existing Notes, as amended hereby, pursuant to this <U>Section</U><U></U><U>&nbsp;3</U>. At the request of any Holder, the Company shall execute and deliver a new Note or Notes in the form of the relevant Exhibit (as amended by
this Amendment) to the Note Facility, in exchange for, and in replacement of, each Holder&#146;s Existing Note, within five Business Days of such request, registered in the name of such Holder, in the aggregate outstanding principal amount of such
Existing Note and dated as of the last interest payment date of such Existing Note. Any Notes issued on or after the First Amendment Effective Date shall be in the form of the relevant Exhibit to the Note Facility, as amended by this Amendment. The
parties hereto specifically agree and confirm that the transactions effected hereby and by the Existing Notes shall in no way evidence a new debt of the Company or a novation of the Existing Notes, but rather that all outstanding debt of the Company
in respect of the Existing Notes is continued in full force and effect on the terms and conditions set forth in the Note Facility and the Existing Notes (in each case as modified by this Amendment). All outstanding amounts owing by the Company in
respect of the Existing Notes shall continue to be owing under the Note Facility and the Existing Notes (without any further action required on the part of any Person), and shall be payable in accordance with the Note Facility and the Existing Notes
(in each case as modified by this Amendment). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. To induce New
York Life and the Holders to enter into this Amendment, the Company hereby represents and warrants to New York Life and the Holders that, both before (except with respect to Section&nbsp;4(c) below) and after giving effect to this Amendment: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company and its Subsidiaries (i)&nbsp;is duly organized, validly existing and in good standing under
the laws of the jurisdiction of its organization, (ii)&nbsp;has the requisite corporate or other applicable power and authority, and the legal right (in all material respects), to own and operate its property, to lease the property it operates as
lessee and to conduct the business in which it is currently engaged, (iii)&nbsp;where legally applicable, is duly qualified as a foreign corporation or other applicable entity and in good standing (or equivalent status) under the laws of each
jurisdiction where its ownership, lease or operation of property or the conduct of its business requires such qualification and (iv)&nbsp;is in compliance with all Requirements of Law (provided that no representation or warranty is made in this
subsection 5.3(d) with respect to Requirements of Law referred to in subsections 5.8, 5.10 or 5.15), except to the extent that the failure of the foregoing clauses (a) (only with respect to Subsidiaries of the Company which are not Guarantors), (c)
and (d)&nbsp;to be true and correct could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and performance by the Company of this Amendment (i)&nbsp;are within the Company&#146;s
requisite corporate or other applicable power and authority; (ii)&nbsp;have been duly authorized by all necessary corporate action; (iii)&nbsp;will not violate any Requirement of Law or Contractual Obligation of the Company or any if its
Subsidiaries, except for such violations which, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect; (iv)&nbsp;will not result in, or require, the creation or imposition of any Lien on any of its or
their respective properties or revenues pursuant to any such Requirement of Law or Contractual Obligation which, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect; and (v)&nbsp;will not require any
consent or authorization of, filing with, notice to or other act by or in respect of, any Governmental Authority or any other Person with respect to the Company or any of its Restricted Subsidiaries except for such consents, authorizations, filings,
notices or other acts which, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment has been duly executed and delivered on behalf of the Company. This Amendment constitutes and, upon
execution and delivery thereof, will constitute, a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium and other similar laws relating to or affecting creditors&#146; rights generally, general equitable principles (whether considered in a proceeding in equity or at law) and an implied covenant of good faith and fair
dealing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;After giving effect to this Amendment, the representations and warranties contained in the Note
Facility (except with respect to Section&nbsp;5.6, as disclosed in the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT>
in each case, most recently filed with the Securities and Exchange Commission) and the other Note<B> </B>Documents are true and correct in all material respects as of the First Amendment Effective Date except to the extent that such representations
and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment and the documents, certificates or other writings
delivered to the Holders by or on behalf of the Company in connection with the amendments set forth herein, taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements
therein not misleading in light of the circumstances under which they were made. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the other documents,
certificates or other writings delivered to the Holders by or on behalf of the Company in connection with the amendments set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;No event has occurred and no condition exists that, either before or after giving effect to this Amendment,
constitutes or would constitute a Default or an Event of Default; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;No consent, approval or authorization of, or
registration, filing or declaration with, any Governmental Authority is required in connection with the execution, delivery or performance by the Company of this Amendment; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not paid, nor has it agreed to pay, any fees or other compensation in connection with the
amendments described in Section&nbsp;5(a), (b), (c) and (d)&nbsp;below, apart from an amendment fee equal to 0.10% of the principal amount of notes outstanding (i)&nbsp;under the MetLife Note Agreement in connection with the MetLife Amendment (as
hereinafter defined), and (ii)&nbsp;under the Prudential Shelf Agreement in connection with the Prudential Amendment (as hereinafter defined). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Effectiveness</U>. The amendments set forth in <U>Section</U><U></U><U>&nbsp;2</U> of
this amendment shall become effective on the date on which the following conditions precedent have been satisfied or waived (the first date on which such conditions shall have been so satisfied or waived, the &#147;<U>First Amendment Effective
Date</U>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company, New York Life and the Holders shall have executed and delivered a counterpart of
this Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a fully executed copy of an amendment agreement to the
Existing Credit Facility, dated as of April&nbsp;17, 2020, by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto, in form and substance satisfactory to the Required Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a fully executed copy of an amendment agreement to the MetLife Note Agreement,
dated as of the date hereof (the &#147;<U>MetLife Amendment</U>&#148;), by and among the Company, Metropolitan Life Insurance Company and MetLife Investment Advisors Company, LLC and the other holders of notes party thereto, in form and substance
satisfactory to the Required Holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a fully executed copy of an
amendment agreement to the Prudential Shelf Agreement, dated as of the date hereof (the &#147;<U>Prudential Amendment</U>&#148;), by and among the Company, PGIM, Inc., The Prudential Insurance Company of America and the other holders of notes party
thereto, in form and substance satisfactory to the Required Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a
certificate signed by a Responsible Officer of the Company certifying that the conditions specified in clauses (h)&nbsp;and (i) of this <U>Section</U><U></U><U>&nbsp;5</U> have been satisfied as of the First Amendment Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a certificate of a Secretary or Assistant Secretary of the Company, dated as of the
date hereof, (A)&nbsp;certifying as to the resolutions attached thereto, incumbency of applicable officers and other corporate proceedings relating to the authorization, execution and delivery of this Amendment, and (B)&nbsp;attaching true, correct
and complete copies of the corporate charter and bylaws of the Company or certifying that the corporate charter and bylaws most recently provided to the Holders are still in full force and effect and have not since been amended, restated,
supplemented or otherwise modified in any respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Holders shall have received a good standing certificate
for the Company from the Secretary of State of Delaware, dated of a recent date and such other evidence of the status of the Company as New York Life and the Holders may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Each of the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4</U> above shall be true and
correct as of the date of the execution and delivery of this Amendment and as of the First Amendment Effective Date as if made on and as of such date (or, if any such representation and warranty is expressly stated to have been made as of a specific
date, as of such specific date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default shall have occurred and be continuing on and
as of the First Amendment Effective Date or immediately after giving effect to this Amendment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Each Holder
shall have received payment of an amendment fee of 10 basis points (0.10%) of the principal amount of the outstanding Notes held by such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have paid the reasonable fees and disbursements of the Holders&#146; special counsel in
accordance with <U>Section</U><U></U><U>&nbsp;7</U> below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effects on Note Facility</U>. This
Amendment shall be construed in connection with and as a part of the Note Facility and, except as specifically amended herein, the Note Facility shall continue to be in full force and effect and is hereby in all respects ratified and confirmed. Any
and all notices, requests, certificates and other instruments executed and delivered after the execution and delivery of this Amendment may refer to the Note Facility without making specific reference to this Amendment, but nevertheless all such
references shall include this Amendment unless the context otherwise requires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Without prejudice to the provisions
of Section&nbsp;15 (<I>Expenses, Etc.</I>) of the Note Facility, whether or not the amendments set forth herein become effective, the Company agrees to pay or reimburse New York Life and the Holders for all of their reasonable and invoiced <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the development, preparation and execution of this Amendment and any other documents prepared in connection
herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including, without limitation, the reasonble and documented fees and disbursements of King&nbsp;&amp; Spalding LLP, counsel to New
York Life and the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;<U>GOVERNING LAW; WAIVER OF JURY TRIAL</U>. THIS AMENDMENT SHALL BE
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK EXCLUDING
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">CHOICE-OF-LAW</FONT></FONT> PRINCIPLES OF THE LAW OF SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. EACH PARTY HERETO HEREBY AGREES
AS SET FORTH FURTHER IN SECTION 22.8 OF THE NOTE FACILITY AS IF SUCH SECTION WAS SET FORTH IN FULL HEREIN. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Novation</U>. This Amendment is not intended by the parties to be, and shall not be construed to
be, a novation of the Note Facility or an accord and satisfaction in regard thereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Note
Document</U>. This Amendment shall constitute a &#147;Note Document&#148; for all purposes of the Note Facility and the other Note Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments; Execution in Counterparts; Electronic Execution</U>. This Amendment shall not
constitute an amendment of any other provision of the Note Facility not referred to herein and shall not be construed as a waiver or consent to any further or future action on the part of the Company that would require a waiver or consent of the
Holders or New York Life. Except as expressly amended hereby, the provisions of the Note Facility are and shall remain in full force and effect. This Amendment may be executed in any number of counterparts and by the different parties hereto on
separate counterparts, including by means of facsimile or electronic transmission, each of which when so executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delivery of an executed counterpart of a signature page of this Amendment by telecopy, emailed pdf. or any other electronic means that
reproduces an image of the actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment. The words &#147;execution,&#148; &#147;signed,&#148; &#147;signature,&#148; &#147;delivery,&#148; and
words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include an electronic sound, symbol, or process attached to, or associated with, a
contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record (each an &#147;<U>Electronic Signature</U>&#148;), each of which shall be of the same legal effect, validity or enforceability
as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and
National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that nothing herein shall require New York Life to accept Electronic
Signatures in any form or format without their prior written consent. Without limiting the generality of the foregoing, each party hereto hereby (i)&nbsp;agrees that, for all purposes, including without limitation, in connection with any workout,
restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the New York Life, the Company and the other parties hereto, electronic images of this Amendment or any other Note Documents (in each case, including with respect to
any signature pages thereto) shall have the same legal effect, validity and enforceability as any paper original, and (ii)&nbsp;waives any argument, defense or right to contest the validity or enforceability of this Amendment or any of the other
Note Documents based solely on the lack of paper original copies of this Amendment or any other Note Documents, including with respect to any signature pages hereto or thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. All covenants and
other agreements contained in this Amendment by or on behalf of any of the parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Note) whether so expressed
or not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Any provision of this Amendment that is prohibited or unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall (to
the full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page
intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective proper and duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HENRY SCHEIN, INC.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as the Company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Amodio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Michael Amodio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (New York Life)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="72%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">NYL INVESTORS LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">(as successor in interest to New York Life Investment Management LLC)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">NEW YORK LIFE INSURANCE COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT (BOLI 3)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (New York Life)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT (BOLI <FONT STYLE="white-space:nowrap">3-2)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT (BOLI 30C)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT (BOLI 30D)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (New York Life)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW YORK LIFE INSURANCE AND ANNUITY CORPORATION INSTITUTIONALLY OWNED LIFE INSURANCE SEPARATE ACCOUNT (BOLI 30E)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE BANK OF NEW YORK MELLON, SOLELY IN ITS CAPACITY AS TRUSTEE UNDER THAT CERTAIN TRUST AGREEMENT DATED AS OF JULY 1ST, 2015 BETWEEN NEW YORK LIFE INSURANCE COMPANY, AS GRANTOR, JOHN HANCOCK LIFE INSURANCE COMPANY
(U.S.A.), AS BENEFICIARY, JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK, AS BENEFICIARY, AND THE BANK OF NEW YORK MELLON, AS TRUSTEE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: NYL Investors LLC, its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Carey</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Christopher Carey</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Master Facility Note (New York Life)]</I> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>d948426dex43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Execution Version </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FIRST
AMENDMENT TO SECOND AMENDED AND RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This FIRST AMENDMENT TO SECOND AMENDED AND
RESTATED MULTICURRENCY MASTER NOTE PURCHASE AGREEMENT, dated as of June&nbsp;23, 2020 (this &#147;<U>Amendment</U>&#148;), is among Henry Schein, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), Metropolitan Life Insurance Company and
MetLife Investment Management, LLC (formerly known as MetLife Investment Advisors Company, LLC and MetLife Investment Advisors, LLC) (together, &#147;<U>MetLife</U>&#148;), and each of the holders of the Existing Notes (as defined below) (together,
the &#147;<U>Holders</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W I T N E S S E T H </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, reference is made to that certain $200,000,000 Second Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of
June&nbsp;29, 2018, by and among the Company, MetLife and each Holder party thereto (as amended, restated, modified, or supplemented from time to time, the &#147;<U>Note Facility</U>&#148;), pursuant to which the Company issued and sold to the
Holders its (a) 3.42% Series <FONT STYLE="white-space:nowrap">2017-A</FONT> Senior Notes due June&nbsp;16, 2027 in the original aggregate principal amount of $50,000,000 (as in effect immediately prior to giving effect to this Amendment, the
&#147;<U>Existing 2017 Notes</U>&#148;) and (b) 3.32% Series <FONT STYLE="white-space:nowrap">2018-A</FONT> Senior Notes due January&nbsp;2, 2028 in the original aggregate principal amount of $50,000,000 (as in effect immediately prior to giving
effect to this Amendment, the &#147;<U>Existing 2018 Notes</U>&#148; and, together with the Existing 2017 Notes, collectively, the &#147;<U>Existing Notes</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has requested that the (a)&nbsp;Note Facility be amended by this Amendment in order to, among other things,
(i)&nbsp;extend the Issuance Period and (ii)&nbsp;effect certain changes to the covenant set forth in Section&nbsp;10.9 of the Note Facility and (b)&nbsp;Existing Notes be amended and restated; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, MetLife and the Holders are willing to enter into such amendments and to amend and restate the Existing Notes subject
and pursuant to the terms and conditions of this Amendment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and mutual covenants
contained herein, the parties hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined Terms</U>. Unless otherwise
defined herein, capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Note Facility. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment to the Note Facility</U>. Effective as
of the First Amendment Effective Date, the Note Facility is hereby amended as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Section
2.1 of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1.</B>&nbsp;&nbsp;&nbsp;&nbsp;<U>Facility</U>. MetLife is willing to consider, in its sole discretion and within the
limits which may be authorized for purchase by MetLife Affiliates from time to time, the purchase of Shelf Notes pursuant to this Agreement. The willingness of MetLife to consider such purchase of Shelf Notes is herein called the
&#147;<B>Facility</B>&#148;. At any time the aggregate principal amount of Shelf Notes in Section&nbsp;1.4, minus the aggregate principal amount of Shelf Notes purchased and sold pursuant to this Agreement and outstanding at such time, minus the
aggregate principal amount of Accepted Notes (as hereinafter defined) which have not yet been purchased and sold hereunder prior to such time, is herein called the &#147;<B>Available Facility Amount</B>&#148; at such time. For the purposes of the
preceding sentence, all aggregate principal amounts of Shelf Notes and Accepted Notes shall be calculated in Dollars; with respect to any Shelf Notes denominated or Accepted Notes to be denominated in any Available Currency other than Dollars, the
Dollar Equivalent of Shelf Notes or Accepted Notes shall be used for such calculation. For the avoidance of doubt, the Available Facility Amount shall be increased by the principal amount of any outstanding Shelf Notes which are repaid or prepaid
prior to the expiration of the Issuance Period (but in no event shall the Available Facility Amount exceed $100,000,000 at any time). <B>NOTWITHSTANDING THE WILLINGNESS OF METLIFE TO CONSIDER PURCHASES OF SHELF NOTES BY METLIFE AFFILIATES, THIS
AGREEMENT IS ENTERED INTO ON THE EXPRESS UNDERSTANDING THAT NEITHER METLIFE NOR ANY METLIFE AFFILIATE SHALL BE OBLIGATED TO MAKE OR ACCEPT OFFERS TO PURCHASE SHELF NOTES, OR TO QUOTE RATES, SPREADS OR OTHER TERMS WITH RESPECT TO SPECIFIC PURCHASE OF
SHELF NOTES, AND THE FACILITY SHALL IN NO WAY BE CONSTRUED AS A COMMITMENT BY METLIFE OR ANY METLIFE AFFILIATE.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 2.2(i) of the Note Facility is hereby amended and restated in its entirety as follows:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;June&nbsp;23, 2023 (or if such day is not a Business Day, the Business Day next succeeding such
day) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The first sentence of the first paragraph of Section&nbsp;5 of the Note Facility is hereby
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchasers and the holders of the Notes recognize and acknowledge
that the Company may supplement the following representations and warranties in this Section&nbsp;5, including the Schedules related thereto, pursuant to a Request for Purchase; <U>provided</U> that (i)&nbsp;no such supplement to any representation
or warranty applicable to any particular Closing Day shall change or otherwise modify or be deemed or construed to change or otherwise modify any representation or warranty given on any other Closing Day or any determination of the falseness or
inaccuracy thereof pursuant to Section&nbsp;11(e) and (ii)&nbsp;no supplement to Section&nbsp;5.3 or <U>Schedule 5.3</U> as to any particular Closing Day shall be made after the Company makes a Request for Purchase in respect of such Closing Day.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 5.3 of the Note Facility is hereby
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement and the documents, certificates or other writings
(including the financial statements described in Section&nbsp;5.5 and the financial statements provided pursuant to the terms hereof) delivered to the Purchasers by or on behalf of the Company in connection with the transactions contemplated hereby
(this Agreement and such documents, certificates or other writings and financial statements delivered to each Purchaser prior to the applicable Closing Day being referred to, collectively, as the &#147;<B>Disclosure Documents</B>&#148;), taken as a
whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the Disclosure
Documents, since the end of the most recent fiscal year for which audited financial statements have been furnished there has been no change in the financial condition, operations, business or properties of the Company or any Subsidiary except
changes that individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth
herein or in the Disclosure Documents. For the purposes of this Section&nbsp;5.3, the Disclosure Documents shall be deemed to include all filings made with, or furnished to, the Securities and Exchange Commission by the Company pursuant to sections
13 or 15(d) of the Exchange Act, and the Company shall be deemed to have made delivery of any such Disclosure Document if it shall have timely made such Disclosure Document available on the Securities and Exchange Commission&#146;s Electronic Data
Gathering Analysis, and Retrieval system, or its successor thereto (&#147;<B>EDGAR</B>&#148;). Notwithstanding the foregoing, for purposes of this Section&nbsp;5.3, and only from the First Amendment Effective Date until December&nbsp;31, 2020, the
impacts of the existing Coronavirus pandemic on the business, operations or financial condition of the Company and its Subsidiaries taken as a whole that have occurred and were disclosed in writing to MetLife prior to the First Amendment Effective
Date will be disregarded. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 7.2(a) of the Note Facility is hereby amended and restated
in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenant Compliance</U> &#151; (i) the information required in
order to establish whether the Company was in compliance with the requirements of Section&nbsp;10.9 (including reasonably detailed calculations), (ii) a certification by the Senior Financial Officer that the Company was in compliance with the
requirements of Section&nbsp;10.5(o), Section&nbsp;10.6(a) and (b)(vi) and Section&nbsp;10.7(g)(iii) during the quarterly or annual period covered by the statements then being furnished (including with respect to each such Section, if requested, the
calculations of the maximum or minimum amount, ratio or percentage, as the case may be, permissible under the terms of such Sections, and the calculation of the amount, ratio or percentage then in existence), (iii) a reconciliation of the treatment
of leases which are or would be deemed by GAAP as in effect on the date hereof to be treated as operating leases, in form and substance reasonably satisfactory to the Required Holder and and (iv)&nbsp;with respect to the financial statements
delivered pursuant to Section&nbsp;7.1(a), to the extent the Leverage Spike is accruing as of the date of such certificate, a reasonably detailed calculation of the Consolidated Net Leverage Ratio as of the last day of the four consecutive fiscal
quarters of the Company in respect of which such certificate is delivered; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.5(j) of the Note Facility is hereby
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;judgment and other similar Liens arising in
connection with court proceedings in an aggregate amount not in excess of $10,000,000 (except to the extent covered by independent third-party insurance) <U>provided</U> that the execution or other enforcement of such Liens is effectively stayed and
the claims secured thereby are being actively contested in good faith and by appropriate proceedings; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Subsection 10.9 of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>10.9</B><B>.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Leverage Ratio</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not (i)&nbsp;permit the Consolidated Leverage Ratio (as defined in this Agreement
as in effect prior to the First Amendment Effective Date) at any time during any period of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending on or before March&nbsp;31, 2020 to exceed 3.25 to 1.00,
(ii) permit the Consolidated Net Leverage Ratio at any time during any period of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2020 and on or before March&nbsp;31, 2021 to
exceed 3.75 to 1.00 or (iii)&nbsp;permit the Consolidated Leverage Ratio at any time during any period of four consecutive fiscal quarters of the Company (in each case taken as one accounting period) ending after March&nbsp;31, 2021 to exceed 3.25
to 1.00; <U>provided</U>, that, to the extent the Company consummates during any fiscal quarter of the Company ending after March&nbsp;31, 2021 an acquisition permitted by this Agreement for aggregate cash consideration exceeding $150,000,000 (each,
a &#147;<B>Material Acquisition</B>&#148;), the Company may elect, upon written notice to MetLife and each holder of a Note, which notice shall be provided no later than the last Business Day of the fiscal quarter in which the relevant Material
Acquisition is consummated, to increase the maximum Consolidated Leverage Ratio permitted by this Section&nbsp;10.9(a) to 3.75 to 1.00 for the fiscal quarter in which such Material Acquisition is consummated and the three consecutive fiscal quarters
of the Company following such Material Acquisition (each, a &#147;<B>Four Quarter Period</B>&#148;) (retroactive to the first day of such Four Quarter Period), and the interest rate applicable to the Notes (including, for the avoidance of doubt, the
Leverage Spike, if applicable) shall increase by 0.50% per annum during the period from the first day of the second fiscal quarter of the Company in such Four Quarter Period until the earlier of (i)&nbsp;the last day of such fiscal quarter at the
end of which the Consolidated Leverage Ratio for the four fiscal quarters of the Company then ended did not exceed 3.25 to 1.00 and (ii)&nbsp;the last day of the first fiscal quarter of the Company ending after such Four Quarter Period (each a
&#147;<B>Covenant Reset Date</B>&#148;) (such increase, the &#147;<B>Acquisition Spike</B>&#148;); <U>provided</U> <U>further</U> that, the maximum Consolidated Leverage Ratio may be increased to 3.75 to 1.00 for a Four Quarter Period in connection
with a Material Acquisition no more than three times after the Original Closing Date. For the avoidance of doubt, the Consolidated Leverage Ratio may not exceed 3.25 to 1.00 for the four fiscal quarters of the Company then last ended (in each case
taken as one accounting period) as of the last day of each fiscal quarter that ends after a Covenant Reset Date during a Four Quarter Period. If the Consolidated Leverage Ratio is increased for a Four Quarter Period pursuant to the preceding
sentence, no corresponding increase in the Consolidated Leverage Ratio with respect to a subsequent Material Acquisition may occur until the completion of at least one full fiscal quarter following the last day of such Four Quarter Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If, as of the last day of any four consecutive
fiscal quarters of the Company ending during the Leverage Spike Period, the Consolidated Net Leverage Ratio exceeds 3.00 to 1.00, as evidenced by a certificate of a Senior Financial Officer delivered pursuant to Section&nbsp;7.2(a), the interest
rate applicable to the Notes shall be increased by 1.00% per annum (such increase, the &#147;<B>Leverage Spike</B>&#148;) for a period of time determined as follows: (A)&nbsp;such Leverage Spike shall begin to accrue on the first day of the fiscal
quarter following the fiscal quarter in which such certificate of a Senior Financial Officer was delivered and (B)&nbsp;shall continue to accrue until the Company has provided a certificate of a Senior Financial Officer pursuant to
Section&nbsp;7.2(a) demonstrating that, (x)&nbsp;with respect to any four consecutive fiscal quarters of the Company ending after March&nbsp;31, 2020 and before June&nbsp;30, 2021, as of the last day of the four consecutive fiscal quarters of the
Company in respect of which such certificate is delivered, the Consolidated Net Leverage Ratio is not more than 3.00 to 1.00, or (y)&nbsp;with respect to any four consecutive fiscal quarters of the Company ending on or after June&nbsp;30, 2021, as
of the last day of the four consecutive fiscal quarters of the Company in respect of which such certificate is delivered, the Consolidated Leverage Ratio is not more than 3.25 to 1.00, and in the event such certificate is delivered, the Leverage
Spike shall cease to accrue on the last day of the fiscal quarter in which such certificate is delivered.&nbsp;For the avoidance of doubt, (i)&nbsp;if certificate of a Senior Financial Officer is not delivered on the day it is due in accordance with
Section&nbsp;7.2(a), then the Leverage Spike shall accrue and be determined as if the Consolidated Net Leverage Ratio exceeds 3.00 to 1.00 as of the last day of the four consecutive fiscal quarters of the Company in respect of which such certificate
was due<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>and such Leverage Spike shall continue to accrue at such rate until the next date of determination for the following period.&nbsp;For the avoidance of doubt, if, as of the last day of the
four consecutive fiscal quarters of the Company ending on or after June&nbsp;30, 2021, the Consolidated Leverage Ratio is not more than 3.25 to 1.00, the Leverage Spike shall not accrue with respect to such four consecutive fiscal quarters of the
Company ending on such date or any four consecutive quarters of the Company ending thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Section 10 of the Note Facility is hereby amended
by adding the following new Subsection 10.11 to immediately follow Subsection 10.10 therein: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.11</B>.&nbsp;&nbsp;&nbsp;&nbsp;<B>Restricted Payments</B>. Until the later of (i)&nbsp;termination of the Leverage Spike
Period and (ii)&nbsp;the date that no other Principal Credit Facility has a restriction on the payment of Restricted Payments, the Company will not declare or pay any dividend on, or make any payment on account of, or set apart assets for a sinking
or other analogous fund for, the purchase, redemption, defeasance, retirement or other acquisition of, any Equity Interests of the Company (any such dividend, payment or setting apart, a &#147;<B>Restricted Payment</B>&#148;), whether outstanding on
the First Amendment Effective Date or thereafter, or make any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of the Company or any Subsidiary, except (a)&nbsp;the Company may make
Restricted Payments in the form of Equity Interests of the Company and (b)&nbsp;the Company may make Restricted Payments in cash, in lieu of the issuance of fractional shares, upon the exercise of warrants or upon the conversion or exchange of
Equity Interests of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Section 22 of the Note Facility is hereby amended by adding
the following new Subsection 22.11 to immediately follow Subsection 22.10 therein: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B>22.11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B>Divisions</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">For all purposes under the Financing Documents, in connection with any division or plan of division under Delaware law (or any
comparable event under a different jurisdiction&#146;s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred
from the original Person to the subsequent Person, and (b)&nbsp;if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of Equity Interests at such time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Schedule B of the Note Facility is hereby amended by adding the following new definitions in
alphabetical order: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility</B>&#148; means the
$700,000,000 Credit Agreement dated as of April&nbsp;17, 2020, among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, U.S. Bank, National Association, as syndication agent, the lenders party thereto, and T.D. Bank, N.A.,
ING Bank, N.V., Dublin Branch, MUFG Bank, Ltd., The Bank of New York Mellon and UniCredit Bank, A.G., as <FONT STYLE="white-space:nowrap">co-documentation</FONT> agents, as the same may be amended, supplemented, restated or otherwise modified from
time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Additional Interest</B>&#148; means, at any time, the sum of the Acquisition Spike (if any) and the
Leverage Spike (if any) at such time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cash Equivalents</B>&#148; means, as of any date,
(a)&nbsp;securities issued or directly and fully guaranteed or insured by the U.S. government or any agency or instrumentality thereof having maturities of not more than one year from such date rated at least
<FONT STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof by S&amp;P or A3 or the equivalent thereof by Moody&#146;s, (b)&nbsp;time deposits and certificates of deposits having maturities of not more than one year from such date and
issued by any domestic commercial bank having (i)&nbsp;senior long term unsecured debt rated at least <FONT STYLE="white-space:nowrap">A-</FONT> or the equivalent thereof by S&amp;P or A3 or the equivalent thereof by Moody&#146;s and
(ii)&nbsp;capital and surplus in excess of $100,000,000, (c) commercial paper rated at least <FONT STYLE="white-space:nowrap">A-2</FONT> or the equivalent thereof by S&amp;P or <FONT STYLE="white-space:nowrap">P-2</FONT> or the equivalent thereof by
Moody&#146;s and in either case maturing within 120 days from such date and (d)&nbsp;shares of any money market mutual fund rated at least <FONT STYLE="white-space:nowrap">AA-</FONT> or the equivalent thereof by S&amp;P or at least Aa3 or the
equivalent thereof by Moody&#146;s. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cost Savings</B>&#148; means savings in respect of salary, benefit and other
related expenses of the Company resulting from a reduction in force. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net Debt</B>&#148; means, at
any date of determination, (a)&nbsp;Consolidated Total Debt at such date minus (b)&nbsp;Unrestricted Cash at such date in an aggregate amount not to exceed $250,000,000 under this clause (b). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated Net Leverage Ratio</B>&#148; means, at any date of determination, the ratio of (a)&nbsp;Consolidated Net
Debt on such date to (b)&nbsp;Consolidated EBITDA for the period of the four fiscal quarters ending on (or most recently ended prior to) such date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Designated Charges</B>&#148; means, for any period, subject to the last two sentences of this definition, the sum of
(a)&nbsp;to the extent deducted in computing Consolidated Operating Income for such period, the aggregate of total (i)&nbsp;extraordinary, unusual or <FONT STYLE="white-space:nowrap">non-recurring</FONT> charges and expenses and
(ii)&nbsp;Restructuring Expenses plus (b)&nbsp;Pro Forma Cost Savings for such period. The sum of Restructuring Expenses and Pro Forma Cost Savings for any period shall not exceed (1)&nbsp;in the case of any such period ending on or prior to
December&nbsp;31, 2019, 10% of Consolidated EBITDA for such period, (2)&nbsp;in the case of any such period ending after December&nbsp;31, 2019 and on or prior to March&nbsp;31, 2021, $100,000,000 and (3)&nbsp;in the case of any such period ending
after March&nbsp;31, 2021, 10% of Consolidated EBITDA for such period; Restructuring Expenses and Pro Forma Cost Savings shall be determined on a consolidated basis in accordance with GAAP and calculated consistently with the Company&#146;s
calculation thereof in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. The aggregate amount of Pro Forma Cost Savings for any period of four fiscal quarters ending after
March&nbsp;31, 2020 and on or prior to March&nbsp;31, 2021 shall not exceed $25,000,000. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>First Amendment
Effective Date</B>&#148; has the definition set forth in the First Amendment to Second Amended and Restated Multicurrency Master Note Purchase Agreement, dated as of June&nbsp;23, 2020, among the Company, MetLife and each holder party thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike</B>&#148; is defined in Section&nbsp;10.9(b). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Leverage Spike Period</B>&#148; means the period beginning on the First Amendment Effective Date and continuing
through and until the date on which the Company delivers evidence to the holders that (a)&nbsp;the Company is in compliance with Section&nbsp;10.9 for four consecutive fiscal quarters of the Company ended on or after June&nbsp;30, 2021 and
(b)&nbsp;on such date no Event of Default has occurred or is continuing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Moody&#146;s</B>&#148; means
Moody&#146;s Investors Service, Inc., or any successor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Pro Forma Cost Savings</B>&#148; means (a)&nbsp;in
respect of the four quarters of the Company ending on June&nbsp;30, 2020 the Cost Savings attributable to the fiscal quarter of the Company ending on such date multiplied by three, (b)&nbsp;in respect of the four quarters of the Company ending on
September&nbsp;30, 2020 an amount equal to the Cost Savings attributable to the period of two consecutive fiscal quarters of the Company ending on such date, (c)&nbsp;in respect of the four quarters of the Company ending on December&nbsp;31, 2020
the Cost Savings attributable to the period of three consecutive fiscal quarters of the Company ending on such date multiplied by one third and (d)&nbsp;zero thereafter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Payment</B>&#148; is defined in Section&nbsp;10.11. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restructuring Expenses</B>&#148; means restructuring, consolidation, transaction, integration or other similar charges
and expenses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>S&amp;P</B>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services, a division of The
McGraw-Hill Company, or its successors or assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unrestricted Cash</B>&#148; means, as at any date of
determination, the aggregate amount of cash and Cash Equivalents included in the cash accounts that would be listed on the consolidated balance sheet of the Company and its Subsidiaries, determined on such date on a consolidated basis in accordance
with GAAP and as calculated consistent with the manner disclosed by the Company in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016, to the extent such cash and Cash Equivalents
are not (a)&nbsp;subject to a Lien securing any Indebtedness or other obligations or (b)&nbsp;classified as &#147;restricted.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Consolidated EBITDA</B>&#148; in Schedule B of the Note Facility is
hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consolidated EBITDA</B>&#148; means, for any period,
Consolidated Operating Income plus, without duplication, (a)&nbsp;Consolidated Interest Income, (b)&nbsp;depreciation, (c) amortization, (d)&nbsp;the Designated Charges and (e)&nbsp;to the extent deducted in computing Consolidated Operating Income,
stock-based compensation of the Company and its Subsidiaries in each case for such period and determined on a consolidated basis in accordance with GAAP and, except for Designated Charges consisting of Pro Forma Cost Savings, as calculated
consistent with the manner disclosed by the Company in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Existing Credit
Facility</B>&#148; in Schedule B of the Note Facility is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Existing Credit Facility</B>&#148; means the $750,000,000 Credit Agreement, dated as of April&nbsp;18, 2017 (as
amended by the First Amendment dated as of June&nbsp;29, 2018, and as further amended by the Second Amendment dated as of April&nbsp;17, 2020), among the Company, as borrower, JPMorgan Chase Bank, N.A., as administrative agent, the syndication
agent, the lenders party thereto and JPMorgan Chase Bank, N.A. and U.S. Bank National Association, as joint lead arrangers and joint bookrunners as the same may be amended, supplemented, restated or otherwise modified from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;<B>Principal Credit Facility</B>&#148; in Schedule B of the Note Facility is
hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Principal Credit Facility</B>&#148; means any agreement,
instrument or facility, and any renewal, refinancing, refunding or replacement thereof, or any two or more of any of the foregoing forming part of a common interrelated financing or other transaction (collectively, a &#147;Credit Agreement&#148;) in
respect of which the Company or any Subsidiary is a borrower, guarantor or other obligor, providing for the incurrence of Indebtedness by the Company or any Subsidiary in an aggregate principal amount equal to or in excess of $200,000,000 (or the
equivalent thereof in any other currency), regardless of the principal amount outstanding thereunder from time to time. For the avoidance of doubt, each of the Existing Credit Facility, the <FONT STYLE="white-space:nowrap">364-Day</FONT> Credit
Facility, the New York Life Master Note Facility and the Prudential Shelf Agreement is a Principal Credit Facility. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits 1.4 and 9.8 of the Note Facility are hereby amended to delete the reference to
&#147;Acquisition Spike&#148; therein and to insert in lieu thereof &#147;Additional Interest&#148;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits 1.4, 2, 3, 4.10 and 9.8 of the Note Facility are hereby amended to delete the reference to
&#147;MetLife Investment Advisors Company, LLC&#148; therein and to insert in lieu thereof &#147;MetLife Investment Management, LLC (formerly known as MetLife Investment Advisors Company, LLC and MetLife Investment Advisors, LLC)&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Restatement of Existing Notes</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby agrees, and subject to the satisfaction of the conditions precedent set
forth in <U>Section</U><U></U><U>&nbsp;5</U> of this Amendment, each holder of the Existing 2017 Notes, by its execution of this Agreement, hereby agrees and consents to the amendment and restatement in their entirety of the Existing 2017 Notes,
effective as of the First Amendment Effective Date, on the terms set forth in this <U>Section</U><U></U><U>&nbsp;3(a)</U>. Each Existing 2017 Note is hereby and shall be deemed to be, automatically and without any further action, amended and
restated in its entirety in the form of <U>Exhibit 3(a)</U> hereto (as so amended and restated, and as may be further amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Amended and Restated 2017 Notes</U>&#148;,
such term to include any such notes issued in substitution, replacement or exchange therefore pursuant to Section&nbsp;13 of the Note Facility), except that the payee, date, registration number and principal amount number set forth in each Existing
2017 Note shall remain the same; <U>provided</U>, <U>however</U>, at the request of any holder of an Existing 2017 Note, the Company shall execute and deliver a new Amended and Restated 2017 Note in the form of such<U> Exhibit 3(a)</U> in exchange
for its Existing 2017 Note, registered in the name of such holder, in the aggregate principal amount of the Amended and Restated 2017 Note owing to such holder on the date hereof and dated the date of the last interest payment made to such holder in
respect of its Existing 2017 Note. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company hereby agrees, and subject to the satisfaction
of the conditions precedent set forth in <U>Section</U><U></U><U>&nbsp;5</U> of this Amendment, each holder of the Existing 2018 Notes, by its execution of this Agreement, hereby agrees and consents to the amendment and restatement in their entirety
of the Existing 2018 Notes, effective as of the First Amendment Effective Date, on the terms set forth in this <U>Section</U><U></U><U>&nbsp;3(b)</U>. Each Existing 2018 Note is hereby and shall be deemed to be, automatically and without any further
action, amended and restated in its entirety in the form of <U>Exhibit 3(b)</U> hereto (as so amended and restated, and as may be further amended, restated, supplemented or otherwise modified from time to time, the &#147;<U>Amended and Restated 2018
Notes</U>&#148;, such term to include any such notes issued in substitution, replacement or exchange therefore pursuant to Section&nbsp;13 of the Note Facility; the Amended and Restated 2018 Notes, together with the Amended and Restated 2017 Notes,
collectively, the &#147;<U>Amended and Restated Notes</U>&#148;), except that the payee, date, registration number and principal amount set forth in each Existing 2018 Note shall remain the same; <U>provided</U>, <U>however</U>, at the request of
any holder of an Existing 2018 Note, the Company shall execute and deliver a new Amended and Restated 2018 Note in the form of such <U>Exhibit 3(b)</U> in exchange for its Existing 2018 Note, registered in the name of such holder, in the aggregate
principal amount of the Amended and Restated 2018 Note owing to such holder on the date hereof and dated the date of the last interest payment made to such holder in respect of its Existing 2018 Note. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The parties hereto hereby acknowledge and agree that the amendments to the Existing Notes set forth
herein could have been effected through an agreement or instrument of amendment, and for convenience, the parties hereto have agreed to restate the terms and provisions of the Existing Notes pursuant to this <U>Section</U><U></U><U>&nbsp;3</U>. The
parties hereto specifically agree and confirm that the transactions effected hereby and by the Amended and Restated Notes shall in no way evidence a new debt of the Company or a novation of the Existing Notes, but rather that all outstanding debt of
the Company in respect of the Existing Notes is continued in full force and effect on the terms and conditions set forth in the Note Facility (as modified by this Amendment) and the Amended and Restated Notes. All outstanding amounts owing by the
Company in respect of the Existing Notes shall continue to be owing under the Note Facility and the Amended and Restated Notes (without any further action required on the part of any Person), and shall be payable in accordance with the Note Facility
(as modified by this Amendment) and the Amended and Restated Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. To induce
MetLife and the Holders to enter into this Amendment, the Company hereby represents and warrants to MetLife and the Holders that, both before (except with respect to Section&nbsp;4(f) below) and after giving effect to this Amendment: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a corporation duly organized, validly existing and in good standing under the laws of
its jurisdiction of incorporation, and is duly qualified as a foreign corporation, where legally applicable, and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the
failure to be so qualified or in good standing could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has the corporate power and authority, in all material respects, to own or hold under
lease the properties it purports to own or hold under lease, to transact the business it transacts, to execute and deliver this Amendment and to perform the provisions hereof and thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment has been duly authorized by all necessary corporate action on the part of the
Company, and this Amendment constitutes a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by (i)&nbsp;applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting the enforcement of creditors&#146; rights generally and (ii)&nbsp;general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment and the documents, certificates or other writings delivered to the Holders by or
on behalf of the Company in connection with the amendments set forth herein, taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light
of the circumstances under which they were made. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the other documents, certificates or other writings
delivered to the Holders by or on behalf of the Company in connection with the amendments set forth herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;No event has occurred and no condition exists that, either before or after giving effect to this
Amendment, constitutes or would constitute a Default or an Event of Default. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;No consent,
approval or authorization of, or registration, filing or declaration with, any Governmental Authority is required in connection with the execution, delivery or performance by the Company of this Amendment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;After giving effect to this Amendment, the representations and warranties contained in the Note
Facility (except with respect to Section&nbsp;5.8, as disclosed in the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT>
in each case, most recently filed with the Securities and Exchange Commission) and the other Financing<B> </B>Documents are true and correct in all material respects as of the First Amendment Effective Date except to the extent that such
representations and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects as of such earlier date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not paid, nor has it agreed to
pay, any fees or other compensation in connection with the amendments described in Section&nbsp;5(b), (c), and (d)&nbsp;below, apart from an amendment fee equal to ten basis points (0.10%) of the principal amount of notes outstanding (i)&nbsp;under
the Prudential Shelf Agreement in connection with the Prudential Amendment (as hereinafter defined) and (ii)&nbsp;under the New York Life Shelf Agreement in connection with the New York Life Amendment (as hereinafter defined). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Effectiveness</U>. The amendments set forth in <U>Section</U><U></U><U>&nbsp;2</U> and
the amendment and restatement of the Existing Notes set forth in <U>Section</U><U></U><U>&nbsp;3</U> shall become effective on the first date on which the following conditions precedent have been satisfied or waived (the first date on which such
conditions shall have been so satisfied or waived, the &#147;<U>First Amendment Effective Date</U>&#148;): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company, MetLife and the Holders shall have executed and delivered a counterpart of this
Amendment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders shall have received a fully executed copy of an amendment
agreement to the Existing Credit Facility, dated as of April&nbsp;17, 2020 (the &#147;<U>Bank Amendment</U>&#148;), by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto, in form and substance
satisfactory to the Required Holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders shall have received a fully
executed copy of an amendment agreement to the New York Life Master Note Facility, dated as of the date hereof (the &#147;<U>New York Life Amendment</U>&#148;), by and among the Company, NYL Investors LLC and the other holders of notes party
thereto, in form and substance satisfactory to the Required Holders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders
shall have received a fully executed copy of an amendment agreement to the Prudential Shelf Agreement, dated as of the date hereof (the &#147;<U>Prudential Amendment</U>&#148;), by and among the Company, PGIM, Inc., The Prudential Insurance Company
of America and the other holders of notes party thereto, in form and substance satisfactory to the Required Holders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders shall have received a certificate signed by a Responsible Officer of the
Company, in form and substance satisfactory to the Holders, certifying that the conditions specified in clauses (h)&nbsp;and (i) of this <U>Section</U><U></U><U>&nbsp;5</U> has been satisfied as of the First Amendment Effective Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders shall have received a certificate of a Secretary or Assistant Secretary of
the Company, dated as of the date hereof, (i)&nbsp;certifying as to the resolutions attached thereto, incumbency of applicable officers and other corporate proceedings relating to the authorization, execution and delivery of this Amendment and the
Amended and Restated Notes, and (ii)&nbsp;attaching true, correct and complete copies of the corporate charter and bylaws of the Company or certifying that the corporate charter and bylaws most recently provided to the Holders are still in full
force and effect and have not since been amended, restated, supplemented or otherwise modified in any respect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;MetLife and the Holders shall have received a
good standing certificate for the Company from the Secretary of State of Delaware, dated of a recent date, and such other evidence of the status of the Company as MetLife and the Holders may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Each of the representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;4</U> above
shall be true and correct as of the date of the execution and delivery of this Amendment and as of the First Amendment Effective Date as if made on and as of such date (or if any representation and warranty is expressly stated to have been made as
of a specific date, as of such specific date). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;No Default or Event of Default shall have
occurred and be continuing on and as of the First Amendment Effective Date or immediately after giving effect to this Amendment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Each holder of the Notes shall have received payment of an amendment fee of 10 basis points (0.10%)
of the principal amount of the outstanding Notes held by such holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have
paid the reasonable fees and disbursements of the Holders&#146; special counsel in accordance with <U>Section</U><U></U><U>&nbsp;7</U> below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effects on Note Facility</U>. This Amendment shall be construed in connection with and as a part of
the Note Facility and, except as specifically amended herein, the Note Facility shall continue to be in full force and effect and is hereby in all respects ratified and confirmed. Any and all notices, requests, certificates and other instruments
executed and delivered after the execution and delivery of this Amendment may refer to the Note Facility without making specific reference to this Amendment, but nevertheless all such references shall include this Amendment unless the context
otherwise requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Without prejudice to the provisions of Section&nbsp;15
(<I>Expenses, Etc.</I>) of the Note Facility, whether or not the amendments set forth herein become effective, the Company agrees to pay or reimburse MetLife and the Holders for all of their reasonable and invoiced <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the development, preparation and execution of this Amendment and any other documents prepared in connection herewith or therewith, and the
consummation and administration of the transactions contemplated hereby and thereby, including, without limitation, the reasonble and documented fees and disbursements of Morgan, Lewis&nbsp;&amp; Bockius LLP, counsel to MetLife and the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;<U>GOVERNING LAW; JURISDICTION AND PROCESS; WAIVER OF JURY TRIAL</U>. THIS AMENDMENT SHALL BE CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE LAW OF THE STATE OF NEW YORK EXCLUDING <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">CHOICE-OF-LAW</FONT></FONT> PRINCIPLES OF THE LAW OF
SUCH STATE THAT WOULD PERMIT THE APPLICATION OF THE LAWS OF A JURISDICTION OTHER THAN SUCH STATE. EACH PARTY HERETO HEREBY AGREES AS SET FORTH FURTHER IN SECTION 22.8 OF THE NOTE FACILITY AS IF SUCH SECTION WAS SET FORTH IN FULL HEREIN. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Novation</U>. This Amendment is not intended by
the parties to be, and shall not be construed to be, a novation of the Note Facility or an accord and satisfaction in regard thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing Document</U>. This Amendment shall constitute a &#147;Financing Document&#148; for all
purposes of the Note Facility and the other Financing Documents. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments; Execution in
Counterparts; Electronic Execution</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment shall not constitute an amendment of any
other provision of the Note Facility not referred to herein and shall not be construed as a waiver or consent to any further or future action on the part of the Company that would require a waiver or consent of the Holders or MetLife. Except as
expressly amended hereby, the provisions of the Note Facility are and shall remain in full force and effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;This Amendment may be executed in any number of counterparts and by the different parties hereto on
separate counterparts, including by means of facsimile or electronic transmission, each of which when so executed and delivered shall be an original, but all of which shall together constitute one and the same instrument. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Delivery of an executed counterpart of a signature page of this Amendment by telecopy, emailed pdf.
or any other electronic means that reproduces an image of the actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment. The words &#147;execution,&#148; &#147;signed,&#148;
&#147;signature,&#148; &#147;delivery,&#148; and words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include an electronic sound, symbol, or
process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record (each an &#147;<U>Electronic Signature</U>&#148;), each of which shall be of the same
legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal
Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; <U>provided</U> that nothing herein shall require
MetLife or the Holders to accept Electronic Signatures in any form or format without their prior written consent. Without limiting the generality of the foregoing, each party hereto hereby (i)&nbsp;agrees that, for all purposes, including without
limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the MetLife, the Company and the other parties hereto, electronic images of this Amendment or any other Financing
Documents (in each case, including with respect to any signature pages thereto) shall have the same legal effect, validity and enforceability as any paper original, and (ii)&nbsp;waives any argument, defense or right to contest the validity or
enforceability of this Amendment or any of the other Financing Documents based solely on the lack of paper original copies of this Amendment or any other Financing Documents, including with respect to any signature pages hereto or thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. All covenants and
other agreements contained in this Amendment by or on behalf of any of the parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Note) whether so expressed
or not. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Any provision of this Amendment that is prohibited or unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall (to
the full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page
intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective proper and duly authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HENRY SCHEIN, INC.,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as the
Company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Amodio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael Amodio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Multicurrency Master Note Purchase Agreement (MetLife)]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>METLIFE INVESTMENT MANAGEMENT, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Wills</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">John Wills</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>METROPOLITAN LIFE INSURANCE COMPANY</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>METLIFE INSURANCE K.K.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>METLIFE REINSURANCE COMPANY OF CHARLESTON</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>FARMERS NEW WORLD LIFE INSURANCE COMPANY</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>ZURICH AMERICAN INSURANCE COMPANY</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>PENSION AND SAVINGS COMMITTEE, ON BEHALF OF THE ZURICH AMERICAN INSURANCE COMPANY MASTER RETIREMENT TRUST</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>ZURICH INSURANCE COMPANY LTD, BERMUDA BRANCH</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>TRANSATLANTIC REINSURANCE COMPANY</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>BRIGHTHOUSE LIFE INSURANCE COMPANY</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: MetLife Investment Management, LLC, Its Investment Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Wills</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">John Wills</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
First Amendment to Second A&amp;R Multicurrency Master Note Purchase Agreement (MetLife)]</I> </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>d948426dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION COPY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 6 TO RECEIVABLES PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AMENDMENT NO. 6 TO RECEIVABLES PURCHASE AGREEMENT, dated as of June&nbsp;22, 2020 (this &#147;<U>Amendment</U>&#148;), is entered into
among HSFR, INC., a Delaware corporation, as seller (the &#147;<U>Seller</U>&#148;), THE PURCHASERS LISTED ON THE SIGNATURE PAGES HERETO (the &#147;<U>Purchasers</U>&#148;), THE PURCHASER AGENTS LISTED ON THE SIGNATURE PAGES HERETO (the
&#147;<U>Purchaser Agents</U>&#148;), MUFG BANK, LTD. (F/K/A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as agent (in such capacity, together with its successors and assigns in such capacity, the &#147;<U>Agent</U>&#148;) for each Purchaser Group, and,
solely with respect to <U>Section</U><U></U><U>&nbsp;10</U>, HENRY SCHEIN, INC. (&#147;<U>HS</U>&#148;), a Delaware corporation, as performance guarantor (the &#147;<U>Performance Guarantor</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BACKGROUND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Seller,
HS, as initial Servicer, Purchasers, Purchaser Agents and Agent are parties to a Receivables Purchase Agreement, dated as of April&nbsp;17, 2013 (as amended by that certain Omnibus Amendment No.&nbsp;1, dated as of July&nbsp;22, 2013, that certain
Omnibus Amendment No.&nbsp;2, dated as of April&nbsp;21, 2014, that certain Amendment No.&nbsp;1 to Receivables Purchase Agreement, dated as of September&nbsp;22, 2014, that certain Amendment No.&nbsp;2 to Receivables Purchase Agreement, dated as of
April&nbsp;14, 2015, that certain Amendment No.&nbsp;3 to Receivables Purchase Agreement, dated as of June&nbsp;1, 2016, that certain Amendment No.&nbsp;4 to Receivables Purchase Agreement, dated as of July&nbsp;6, 2017, that certain Amendment
No.&nbsp;5 to Receivables Purchase Agreement, dated as of March&nbsp;13, 2019, and as further amended, restated, modified or supplemented through the date hereof, the &#147;<U>Receivables Purchase Agreement</U>&#148;). The parties are entering into
this Amendment to amend or otherwise modify the Receivables Purchase Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. Capitalized terms are used in this Amendment as defined in Exhibit I to the Receivables Purchase
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments to Receivables Purchase Agreement</U>. The parties to the Receivables Purchase
Agreement hereby agree that the Receivables Purchase Agreement is hereby amended as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Section 4.5 of
the Receivables Purchase Agreement is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Section&nbsp;4.5 <U>Effect of
Benchmark Transition Event</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Benchmark Replacement</U>. Notwithstanding anything to the
contrary herein or in any other Transaction Document, upon the occurrence of a Benchmark Transition Event or an Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election, as applicable, the Agent and the Seller may amend this Agreement to
replace the LIBO Rate with a Benchmark Replacement. Any such amendment with respect to a Benchmark Transition Event will become effective at 5:00 p.m. on the fifth (5th) Business Day after the Agent has posted such proposed amendment to all
Purchasers, Purchaser Agents and the Seller so long as the Agent has not received, by such time, written notice of objection to such amendment from the Purchaser Agents comprising the Required Purchaser Agents. Any such amendment with respect to an
Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election will become effective on the date that Purchaser Agents comprising the Required Purchaser Agents have delivered to the Agent written notice that such Required Purchaser Agents accept such
amendment. No replacement of the LIBO Rate with a Benchmark Replacement pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U> will occur prior to the applicable Benchmark Transition Start Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Benchmark Replacement Conforming Changes</U>.
In connection with the implementation of a Benchmark Replacement, the Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Transaction
Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices; Standards for Decisions and Determinations</U>. The Agent will promptly notify the
Seller, Purchasers and the Purchaser Agents of (i)&nbsp;any occurrence of a Benchmark Transition Event or an Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election, as applicable, and its related Benchmark Replacement Date and Benchmark
Transition Start Date, (ii)&nbsp;the implementation of any Benchmark Replacement, (iii)&nbsp;the effectiveness of any Benchmark Replacement Conforming Changes and (iv)&nbsp;the commencement or conclusion of any Benchmark Unavailability Period. Any
determination, decision or election that may be made by the Agent or Purchaser Agents pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U>, including any determination with respect to a tenor, rate or adjustment or of the occurrence or <FONT
STYLE="white-space:nowrap">non-occurrence</FONT> of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their sole discretion and
without consent from any other party hereto, except, in each case, as expressly required pursuant to this <U>Section</U><U></U><U>&nbsp;4.5</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Benchmark Unavailability Period</U>. Upon the Seller&#146;s receipt of notice of the commencement
of a Benchmark Unavailability Period, (i)&nbsp;no Purchases shall be funded at the LIBO Rate or at the Alternate Base Rate determined by reference to the LIBO Rate and (ii)&nbsp;the Yield for any outstanding portions of the Invested Amount then
funded at the LIBO Rate or at the Alternate Base Rate determined by reference to the LIBO Rate shall, on the last day of the then current Interest Period, be converted to the Alternate Base Rate determined by reference to clause (ii)&nbsp;of the
definition of the Alternate Base Rate.&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Section 9.1(f) of the Receivables Purchase Agreement is hereby
amended and restated in its entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(f)&nbsp;&nbsp;&nbsp;&nbsp;(i) the average of the Delinquency
Ratios, computed for each of the immediately preceding three Calculation Periods, shall exceed (A)&nbsp;with respect to each Calculation Period ending on or prior to May&nbsp;30, 2020, 14.50%; (B) with respect to the Calculation Periods ending on
June&nbsp;27, 2020, August&nbsp;1, 2020, August&nbsp;29, 2020 and September&nbsp;26, 2020, 18.50%; (C) with respect to the Calculation Period ending on October&nbsp;31, 2020, 16.00%; and (D)&nbsp;with respect to each Calculation Period beginning
after October&nbsp;31, 2020, 14.50%; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the average of the Default Ratios, computed for each of the immediately
preceding three Calculation Periods, shall exceed (A)&nbsp;with respect to each Calculation Period ending on or prior to May&nbsp;30, 2020, 2.50%; (B) with respect to the Calculation Periods ending on June&nbsp;27, 2020, August&nbsp;1, 2020,
August&nbsp;29, 2020, September&nbsp;26, 2020, October&nbsp;31, 2020 and November&nbsp;28, 2020, 6.00%; and (C)&nbsp;with respect to each Calculation Period beginning after November&nbsp;28, 2020, 2.50%; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the average of the Dilution Ratios, computed for each of the immediately preceding three Calculation Periods, shall
exceed (A)&nbsp;with respect to any Calculation Period ending on or prior to May&nbsp;30, 2020, 6.25%; (B) with respect to the Calculation Periods ending on June&nbsp;27, 2020, August&nbsp;1, 2020, August&nbsp;29, 2020, September&nbsp;26, 2020, and
October&nbsp;31, 2020, 9.50%; and (C)&nbsp;with respect to each Calculation Period beginning after October&nbsp;31, 2020, 6.25%; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the average of the Portfolio Turnover, computed for each of the immediately preceding three Calculation Periods shall
exceed (A)&nbsp;with respect to each Calculation Period ending on or prior to September&nbsp;26, 2020, 70 days; and (B)&nbsp;with respect to each Calculation Period beginning after September&nbsp;26, 2020, 50 days; or&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The definition &#147;Scheduled Facility Termination Date&#148; in Exhibit I to the Receivables Purchase Agreement
is hereby amended and restated in its entirety to read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>&#147;Scheduled Facility Termination
Date&#148;</I></B> means June&nbsp;12, 2023; provided that the Seller may, with the prior written consent of the Agent and each Purchaser, extend the then existing Scheduled Facility Termination Date for a term of one year by providing written
notice to the Agent on or before each anniversary of April 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> that is two years prior to the then existing Scheduled Facility Termination Date of its request to extend the then existing
Scheduled Facility Termination Date for one year.&#148;. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#147;Replacement Rate&#148; in
Exhibit I to the Receivables Purchase Agreement is hereby deleted in its entirety. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The following new
definitions are hereby added to Exhibit I to the Receivables Purchase Agreement in appropriate alphabetical sequence: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><I>Benchmark Replacement</I></B>&#148; means the sum of: (a)&nbsp;the alternate benchmark rate (which may
include Term SOFR) that has been selected by the Agent and the Seller giving due consideration to (i)&nbsp;any selection or recommendation of a replacement rate or the mechanism for determining such a rate by the Relevant Governmental Body or
(ii)&nbsp;any evolving or then-prevailing market convention for determining a rate of interest as a replacement to LIBO Rate for U.S. dollar-denominated syndicated credit facilities and (b)&nbsp;the Benchmark Replacement Adjustment; provided that,
if the Benchmark Replacement as so determined would be less than zero, the Benchmark Replacement will be deemed to be zero for the purposes of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Replacement Adjustment</I></B>&#148; means, with
respect to any replacement of the LIBO Rate with an Unadjusted Benchmark Replacement for each applicable Interest Period, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative
value or zero) that has been selected by the Agent and the Seller giving due consideration to (i)&nbsp;any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of
LIBO Rate with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (ii)&nbsp;any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread
adjustment, for the replacement of LIBO Rate with the applicable Unadjusted Benchmark Replacement for U.S. dollar-denominated syndicated credit facilities at such time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Replacement Conforming Changes</I></B>&#148; means, with respect to any Benchmark Replacement, any
technical, administrative or operational changes (including changes to the definition of &#147;Alternate Base Rate,&#148; the definition of &#147;Interest Period,&#148; timing and frequency of determining rates and making payments of interest and
other administrative matters) that the Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Agent in a manner substantially consistent with market
practice (or, if the Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Agent determines that no market practice for the administration of the Benchmark Replacement exists, in such other
manner of administration as the Agent decides is reasonably necessary in connection with the administration of this Agreement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Replacement Date</I></B>&#148; means the earlier to occur of the following events with respect to LIBO
Rate: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;in the case of clause (1)&nbsp;or (2) of the definition of &#147;Benchmark Transition
Event,&#148; the later of (a)&nbsp;the date of the public statement or publication of information referenced therein and (b)&nbsp;the date on which the administrator of LIBO Rate permanently or indefinitely ceases to provide LIBO Rate; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;in the case of clause (3)&nbsp;of the definition of &#147;Benchmark Transition Event,&#148; the date
of the public statement or publication of information referenced therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Transition
Event</I></B>&#148; means the occurrence of one or more of the following events with respect to LIBO Rate: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information by or on behalf of the administrator of LIBO Rate
announcing that such administrator has ceased or will cease to provide LIBO Rate, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide LIBO Rate;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information by the regulatory supervisor for the
administrator of LIBO Rate, the U.S. Federal Reserve System, an insolvency official with jurisdiction over the administrator for LIBO Rate, a resolution authority with jurisdiction over the administrator for LIBO Rate or a court or an entity with
similar insolvency or resolution authority over the administrator for LIBO Rate, which states that the administrator of LIBO Rate has ceased or will cease to provide LIBO Rate permanently or indefinitely, provided that, at the time of such statement
or publication, there is no successor administrator that will continue to provide LIBO Rate; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;a public statement or publication of information
by the regulatory supervisor for the administrator of LIBO Rate announcing that LIBO Rate is no longer representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Transition Start Date</I></B>&#148; means (a)&nbsp;in the case of a Benchmark Transition Event, the
earlier of (i)&nbsp;the applicable Benchmark Replacement Date and (ii)&nbsp;if such Benchmark Transition Event is a public statement or publication of information of a prospective event, the 90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>
day prior to the expected date of such event as of such public statement or publication of information (or if the expected date of such prospective event is fewer than 90 days after such statement or publication, the date of such statement or
publication) and (b)&nbsp;in the case of an Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election, the date specified by the Agent or the Required Purchaser Agents, as applicable, by notice to the Seller, the Agent (in the case of such
notice by the Required Purchaser Agents), the Purchasers and the Purchaser Agents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Benchmark Unavailability
Period</I></B>&#148; means, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBO Rate and solely to the extent that the LIBO Rate has not been replaced with a Benchmark Replacement, the period
(x)&nbsp;beginning at the time that such Benchmark Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the LIBO Rate for all purposes hereunder in accordance with <U>Section</U><U></U><U>&nbsp;4.5</U> and
(y)&nbsp;ending at the time that a Benchmark Replacement has replaced the LIBO Rate for all purposes hereunder pursuant to <U>Section</U><U></U><U>&nbsp;4.5</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election</I></B>&#148; means the occurrence of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;(i) a determination by the Agent or (ii)&nbsp;a notification by the Required Purchaser Agents to the
Agent (with a copy to the Seller) that the Required Purchaser Agents have determined that U.S. dollar-denominated syndicated credit facilities being executed at such time, or that include language similar to that contained in
<U>Section</U><U></U><U>&nbsp;4.5</U> are being executed or amended, as applicable, to incorporate or adopt a new benchmark interest rate to replace LIBO Rate, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;(i) the election by the Agent or (ii)&nbsp;the election by the Required Purchaser Agents to declare
that an Early <FONT STYLE="white-space:nowrap">Opt-in</FONT> Election has occurred and the provision, as applicable, by the Agent of written notice of such election to the Seller, the Purchasers and the Purchaser Agents or by the Required Purchaser
Agents of written notice of such election to the Agent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Federal Reserve Bank of New York&#146;s
Website</I></B>&#148; means the website of the Federal Reserve Bank of New York at http://www.newyorkfed.org, or any successor source. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Relevant Governmental Body</I></B>&#148; means the Federal Reserve Board and/or the Federal Reserve Bank of New
York, or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York or any successor thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>SOFR</I></B>&#148; with respect to any day means the secured
overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark, (or a successor administrator) on the Federal Reserve Bank of New York&#146;s Website. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Term SOFR</I></B>&#148; means the forward-looking term rate based on SOFR that has been selected or recommended by
the Relevant Governmental Body. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Unadjusted Benchmark Replacement</I></B>&#148; means the Benchmark Replacement
excluding the Benchmark Replacement Adjustment.&#148;. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Exhibit XIV to the Receivables Purchase Agreement is
hereby replaced in its entirety with <U>Schedule A</U> attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>.
The Seller hereby certifies, represents and warrants to the Agent, each Purchaser Agent and each Purchaser that on and as of the date hereof: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;each of its representations and warranties contained in Article V of the Receivables Purchase Agreement is true and
correct, in all material respects, on and as of the date hereof; provided&nbsp;that, for purposes of the representation in Section&nbsp;5.1(q)(ii) of the Receivables Purchase Agreement, and only from December&nbsp;31, 2019 until July&nbsp;1, 2020,
the impacts of the existing Coronavirus pandemic on the business, operations or financial condition of the Seller and its Subsidiaries taken as a whole will be disregarded; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;no Termination Event or Unmatured Termination Event exists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Effectiveness</U>. This Amendment shall become effective on the date (the &#147;<U>Effective
Date</U>&#148;) when each Purchaser Agent shall have received: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;counterparts of this Amendment duly executed by
the other parties hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;a copy of the resolutions of the Board of Directors of each Seller Party and
Performance Guarantor certified by its Secretary authorizing such Person&#146;s execution, delivery and performance of this Amendment and the performance of its obligations under the Receivables Purchase Agreement (as amended by this Amendment);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;counterparts of that certain Fourth Amended and Restated Fee Letter, dated as of the date hereof, duly
executed by the parties thereto; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the payment of all fees due and owing under the Fourth Amended and
Restated Fee Letter on the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Ratification</U>. This Amendment constitutes an amendment to
the Receivables Purchase Agreement. After the execution and delivery of this Amendment, all references to the Receivables Purchase Agreement in any document shall be deemed to refer to the Receivables Purchase Agreement as amended by this Amendment,
unless the context otherwise requires. Except as amended above, the Receivables Purchase Agreement is hereby ratified in all respects. Except as set forth above, the execution, delivery and effectiveness of this Amendment shall not operate as an
amendment or waiver of any right, power or remedy of the parties hereto under the Receivables Purchase Agreement, nor constitute an amendment or waiver of any provision of the Receivables Purchase Agreement. This Amendment shall not constitute a
course of dealing among the parties hereto at variance with the Receivables Purchase Agreement such as to require further notice by any of the Agent, the Purchaser Agents or the Purchasers to require strict compliance with the terms of the
Receivables Purchase Agreement in the future, as amended by this Amendment, except as expressly set forth herein. The Seller hereby acknowledges and expressly agrees that each of the Agent, the Purchaser Agents and the Purchasers reserves the right
to, and does in fact, require strict compliance with all terms and provisions of the Receivables Purchase Agreement, as amended herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Amendment may be executed in any number of counterparts and by different parties on
separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Counterparts of this Amendment may be delivered by facsimile transmission or other
electronic transmission, and such counterparts shall be as effective as if original counterparts had been physically delivered, and thereafter shall be binding on the parties hereto and their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Amendment shall be governed by, and construed in accordance with the law of the State of
New York without regard to the principles of conflicts of law thereof (other than Sections <FONT STYLE="white-space:nowrap">5-1401</FONT> and <FONT STYLE="white-space:nowrap">5-1402</FONT> of the New York General Obligations Law). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Section Headings</U>. The various headings of this Amendment are inserted for convenience only and shall not
affect the meaning or interpretation of this Amendment, the Receivables Purchase Agreement or any other Transaction Document or any provision hereof or thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transaction Document</U>. This Amendment shall constitute a Transaction Document under the Receivables Purchase
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Ratification of Performance Undertaking</U>. After giving effect to this Amendment and the
transactions contemplated hereby, all of the provisions of the Performance Undertaking shall remain in full force and effect and the Performance Guarantor hereby ratifies and affirms the Performance Undertaking and acknowledges that the Performance
Undertaking has continued and shall continue in full force and effect in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Pages Follow] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by
their respective officers hereunto duly authorized as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HSFR INC.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as Seller</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Amodio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Michael Amodio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><U>Solely with respect to Section&nbsp;10:</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HENRY SCHEIN, INC.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as Performance Guarantor</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Amodio</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Michael Amodio</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President and Treasurer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MUFG BANK, LTD. (F/K/A THE BANK OF</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">TOKYO-MITSUBISHI UFJ, LTD.), as Purchaser</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Agent for Victory Receivables Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Williams</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Williams</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">VICTORY RECEIVABLES CORPORATION,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as an Uncommitted Purchaser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin R. Corrigan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Kevin R. Corrigan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MUFG BANK, LTD. (F/K/A THE BANK OF</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">TOKYO-MITSUBISHI UFJ, LTD.), as Related</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Committed Purchaser for Victory Receivables</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Williams</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Williams</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">MUFG BANK, LTD. (F/K/A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.),</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as Agent</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">by</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Williams</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Eric Williams</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE></DIV> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>d948426dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;


<IMG SRC="g948426gra0072a.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">


<IMG SRC="g948426gra0072b.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g948426gra072c.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>FOR IMMEDIATE RELEASE </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HENRY SCHEIN AMENDS AND EXTENDS FINANCING FACILITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Company Amends and Extends $350 Million Credit Facility and $1 Billion Private Placement Shelf Facilities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MELVILLE, N.Y., June. 25, 2020 </B>&#151; Henry Schein, Inc. (Nasdaq: HSIC), the world&#146;s largest provider of health care solutions to office-based
dental and medical professionals, today announced the successful completion of amendments and extensions of certain of its financing facilities, which enhances the Company&#146;s liquidity and financial flexibility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Henry Schein amended and extended its existing $350&nbsp;million facility with a bank, based on the securitization of its accounts receivable.
The maturity of the facility was extended to June 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s $1&nbsp;billion private placement shelf facilities with three
leading insurance companies were also amended and extended. These shelf facilities are uncommitted and will, subject to the terms and conditions set forth in each, allow the Company to issue senior promissory notes to the lenders at fixed rate terms
to be agreed upon at the time of issuance during a three-year period through June 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amendment to these facilities most notably
includes the temporary amendment of the Company&#146;s covenant calculation to reflect Net Debt instead of Gross Debt, as well as an increase in the maximum leverage allowed under the covenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The amendments and extensions of these facilities, along with the $700M financing announced on April&nbsp;20, 2020, increases our
financial flexibility in a challenging global economy,&#148; said Steven Paladino, Executive Vice President and Chief Financial Officer of Henry Schein. &#147;These facilities support our efforts to navigate the challenges related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic while also helping to position Henry Schein for future growth and success.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Henry
Schein, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Henry Schein, Inc.&nbsp;(Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and
technology. With more than 19,000 <U>Team</U><U> </U><U>Schein</U><U> </U><U>Members</U><U> </U>worldwide, the Company&#146;s network of trusted advisors provides more than 1&nbsp;million customers globally with more than 300 valued solutions that
improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based <U>denta</U>l and <U>medica</U>l practitioners work more efficiently so they can provide quality care more
effectively. These solutions also support <U>dental</U><U> </U><U>laboratories</U><U>,</U><U>&nbsp;</U><U>government</U><U> </U><U>and</U><U> </U><U>institutional</U><U> </U><U>healthcare</U><U> </U><U>clinics</U>, as well as other alternate care
sites. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Henry Schein, Inc. &#9679; 135 Duryea
Road &#9679; Melville, New York 11747 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Henry Schein operates through a centralized and automated distribution network, with a selection of more
than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A FORTUNE 500 Company and a member of the S&amp;P 500<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> index, Henry Schein is headquartered in
Melville, N.Y., and has operations or affiliates in 31 countries. The Company&#146;s sales from continuing operations reached $10.0&nbsp;billion in 2019, and have grown at a compound annual rate of approximately 13&nbsp;percent since Henry Schein
became a public company in 1995. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, visit Henry Schein at <U>www.henryschein.com</U>, <U>Facebook.com/</U><U>HenrySchein</U>, and
<U>@</U><U>HenrySchein</U><U> on Twitter</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Note Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the &#147;Safe Harbor&#148; provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks
regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to
risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry
results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as &#147;may,&#148; &#147;could,&#148;
&#147;expect,&#148; &#147;intend,&#148; &#147;believe,&#148; &#147;plan,&#148; &#147;estimate,&#148; &#147;forecast,&#148; &#147;project,&#148; &#147;anticipate,&#148; &#147;to be,&#148; &#147;to make&#148;, &#147;understand or understanding&#148;
&#147;understand,&#148; or other comparable terms. A full discussion of our operations and financial condition, status of litigation matters, including factors that may affect our business and future prospects, is contained in documents we have
filed with the United States Securities and Exchange Commission, or SEC, and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance
to differ materially from current expectations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risk factors and uncertainties that could cause actual results to differ materially from current and
historical results include, but are not limited to: effects of a highly competitive and consolidating market; increased competition by third party online commerce sites; our dependence on third parties for the manufacture and supply of our products;
our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures;
increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic conditions; risks associated with currency fluctuations; risks associated with political and economic uncertainty;
disruptions in financial markets; volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated
with our global operations; risks associated with the Novel Coronavirus Disease <FONT STYLE="white-space:nowrap">2019&nbsp;(COVID-19);&nbsp;risk</FONT> associated with the&nbsp;United Kingdom&#146;s&nbsp;withdrawal from the&nbsp;European Union;
transitional challenges associated with acquisitions, dispositions and joint ventures, including the failure to achieve anticipated synergies/benefits; financial and tax risks associated with acquisitions, dispositions and joint ventures; litigation
risks; new or unanticipated litigation developments and the status of litigation matters; the dependence on our continued product development, technical support and successful marketing in the technology segment; our dependence on third parties for
certain technologically advanced components; risks from disruption to our information systems; cyberattacks or other privacy or data security breaches; certain provisions in our governing documents that may discourage third-party acquisitions of us;
and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.
We undertake no duty and have no obligation to update forward-looking statements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven Paladino </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Vice President and Chief Financial
Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>steven.paladino@henryschein.com</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(631) <FONT
STYLE="white-space:nowrap">843-5500</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carolynne Borders </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>carolynne.borders@henryschein.com</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(631) <FONT
STYLE="white-space:nowrap">390-8105</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ann Marie Gothard, Vice President, Global Corporate Media Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Annmarie.gothard@henryschein.com</U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(631) <FONT
STYLE="white-space:nowrap">390-8169</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>### </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>hsic-20200622.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/25/2020 3:12:01 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:hsic="http://henryschein.com/20200622"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://henryschein.com/20200622"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hsic-20200622_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hsic-20200622_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>hsic-20200622_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/25/2020 3:12:01 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>hsic-20200622_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/25/2020 3:12:01 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hsic-20200622.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g948426gra0072a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g948426gra0072a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H86YD<F$@
M2W5T;VQI>6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,W
M,P  DI(  @    ,W,P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MW1@Y);'%=-H5]<W<5W;W^TW5C/\ 9Y73&'RB2*<#H=LBY'KG'&* /-?CO_S
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6PO)&&,;<<J3T/ Z>E%% $]%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g948426gra0072b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g948426gra0072b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H86YD<F$@
M2W5T;VQI>6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,Y
M-P  DI(  @    ,Y-P  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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L= ),@Y]3[U>T>SU>T:7^V-52_# >6%MA%L]>G6M2BE[23CRO\A\BYN8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g948426gra072c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g948426gra072c.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#^17AI9@  34T *@    @ ! $[  (
M   1   (2H=I  0    !   (7)R=  $    B   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-H86YD<F$@
M2W5T;VQI>6$    %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,R
M-@  DI(  @    ,R-@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,@]7_,?X444<TNX60?V9!ZO^8_PH_LR#U?\ ,?X444<TNX60?V9!ZO\ F/\
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M'^%%%'-+N%D']F0>K_F/\*/[,@]7_,?X444<TNX60?V9!ZO^8_PH_LR#U?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M_>%W%W:]L4?[CXUO@K*!7W<AOP!02P,$%     @ )3K94)E<G",0!@  G"<
M !,   !X;"]T:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T
M$W-I=MNTF83M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY
M\^XN8NB&B)3R>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2
MP]R"BPA+>!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA
M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M
M&N#C\7@XMLO2BW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_K
MFVB<"HU;3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K
M>A(5M>5 TR  6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T
M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)
MI#-ZG7TZSFN4?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R
M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M'I$<#K]GUF.RI>9L3G;2'87[9A:OS.R]3(OD;LN,B/V H#,$F1")J3T)4%2
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MUM#P0>)S6/$<S.EN?PHO3?*P99TWBISN]F>HQ:#>S@7WOT3Q U!+ P04
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MKB?)^.BVA@8MU&\\(##.(50;+^*1=*:W=Y-[#KO7^H&Q=_OJ5-*/&N/'+7\
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M]_276<]>@C"MA[_)1/TUP.K795]02P,$%     @ )3K94 N/V ,A 0  5P0
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( "4ZV5 GZ(<.@@   +$    0
M      "  >D   !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ )3K94!L-
MS@CO    *P(  !$              ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ )3K94)E<G",0!@  G"<  !,              ( !MP(
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  E.ME0$-_,(IT"  "3
M"P  &               @ 'X"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ )3K94%#(E0Q2 @  [04  !0              ( !RPL
M 'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @ )3K94+JA.8K7 0
M,@8   T              ( !3PX  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  E.ME0%FTC?T,!   \ @  #P              @ %1$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ )3K94/_ )@B]    A0(  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M)3K94 N/V ,A 0  5P0  !,              ( !MA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      H "@"  @  "!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d948426d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hsic-20200622.xsd" xlink:type="simple"/>
    <context id="duration_2020-06-22_to_2020-06-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001000228</identifier>
        </entity>
        <period>
            <startDate>2020-06-22</startDate>
            <endDate>2020-06-22</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-06-22_to_2020-06-22"
      id="Hidden_dei_EntityRegistrantName">HENRY SCHEIN INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-06-22_to_2020-06-22">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-06-22_to_2020-06-22"
      id="Hidden_dei_EntityCentralIndexKey">0001000228</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-06-22_to_2020-06-22">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-06-22_to_2020-06-22">2020-06-22</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-06-22_to_2020-06-22">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-06-22_to_2020-06-22">0-27078</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-06-22_to_2020-06-22">11-3136595</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-06-22_to_2020-06-22">135 Duryea Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-06-22_to_2020-06-22">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-06-22_to_2020-06-22">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-06-22_to_2020-06-22">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-06-22_to_2020-06-22">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-06-22_to_2020-06-22">843-5500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-06-22_to_2020-06-22">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-06-22_to_2020-06-22">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-06-22_to_2020-06-22">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-06-22_to_2020-06-22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-06-22_to_2020-06-22">Common Stock, par value $.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-06-22_to_2020-06-22">HSIC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-06-22_to_2020-06-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-06-22_to_2020-06-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-20-178254-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-178254-xbrl.zip
M4$L#!!0    ( "4ZV5!FZ6$I/!4  $&:   .    9#DT.#0R-F0X:RYH=&WM
M/6MSXKBRWV_5_0\J]NY64A4>!O(BF9S*D,P,9Q.2@NS=W?ME2]@"M&,L5K(3
M.+_^=DNR,6 (D.?,,%5# .O1ZG>W6N+T7Z.!3^Z95%P$'W).H90C+'"%QX/>
MAUP4=O-'.?*OL__^K]-^" VA<:!J'N,?<OTP'-:*Q5%'^@7%W$)/W!?A0;%<
M<H[S)2=?<7*V>:3RX7C(5-*G2U6G(&2O&#_)Z!2(((@&29>'AX>"G@J[>:$L
M8K\B-,I#*R:Y&_<;^3SX.M7MH:([.<?'QT7]-&XZUS*9H%PJ58KXN$,5BYOW
M%7>3YGT6R+%R^XP'!5<,H ?T.2B7$S 4SP("&CG%/ZZOVM!S0/,\4"$-W&2*
M*)0+ 3HNPM.X(5>B6G8.ET!O6R0=1HO:.M V@+6R/SZVKB;-P^SVDZ;%4-)
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M/^I?SIN?+TG]YOJZT6XW;IHO!F!Y)0!_/V]_:30_W]TT]\A%H5X@Y=)^]=@
MM1$W'DPF\5DWK*'<S;"GLX WR^#0[R?<*?5PNGL*Z,QEC98R[,O2?#0+7>[L
MTTWKFIRJ(0UB$![Z/&1Y^,9E8#0?)!V"E"SR'BZ$&Z'SD'*T5K?0VHF;,\T(
MR]F6J"O+209108Y;E\T[TKJ\O6G=O;'4WD921>#7DE"0-G.1)PRNG H1DCC[
M.][N&X,HNB3L,X0NDCSD,-_ER.W3H,?(N1L2>.P<5ZJO"F0&5=$A05A:;"AD
M2';BSXR"0\)42-@]#$VD?LR\W=IBIS\6VUOMU5P:9V==^24FM/R0@W"TYL$
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M(/'TG_7L=3/YZP;1F^%[4Y'I+A$"+ C(E"@^MQ'9!WG1F@'D)1 Z,HP4TZT
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M1.OO."8Q7-MB+@/\0<RD,AR<-PQ*RG%0DE9YJ1!B%?#W3*.E NM4EBJ0FT'
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M73RAPI"C;$+]LZW#KXLH4%E\^0)![&FQ([PQ/.B' __L_P%02P,$%     @
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M'<I_T@YX>D!<2\\J%(F; S<KIIX]8,XFIV(D*1(ZADS.M_@A0XK[S['K*LI
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M$J/!B\@-EHJ-9R6K<KG!%]WK'G$5?A WW!T8=)0S)!C1GN?'7E^=JAFS-?L
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MTOD:$% $>G6BUZM3&J<66];UX'[ VO6"KZ14T&:9GY)L\\4I7G2D <N?>*Y
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M4S=?I/;&-%'F_3G36Y'$C[)W40- <!FNM0!3L?8YE,?4>UWLV=9F)C\]>?N
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M[*Y7:,'=T15N?_/PXN@;7#SM?CD[^']02P,$%     @ )3K94-G<@'.J.@
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MRLP4CH;P91C((D*<QB>_7@/@!CH]+DV"S RD#B@"@#M6KT>2WQ&<4FZ!&+O
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MJ]4Y&\+X#Z$?_$+/R9U/ Y^$[_YU#G^I/L]D "-LM@?XU2D-"&9Q,E"XE&@
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MGK%N'%48P^7U M1KM%H9 _4C@[(U47T8Q]<%-70E16>3)_%@+>=SCR.8X82
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M4]%#JQ-^QP:MO<J@]7 \M>UH^E[HAE%D8NP\ZVV@!2O1:O!$(=U'BVO [GB
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MCCXAM=[E0*T$_[AP8S3&*6UX:O/T;:/C,-$]5"?P]$P4@VT1H)P4/@7$)=;
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M \R%*>HU/P\:,59?38:%<PG?NZ#5B8;5=ER2%J:;Z=EY8M,1J_*6"6\F8)C
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M?13?L:?_<.OI_U(VZ^$RF[5K+Q)$BFOP38+2KI=,>VZBD+.LDV8D.I=TKLM
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MSN#.Z^]Q!B_V/JFVZJN.:JD>_%\+_CY6N*3[L*,'G9U/QZUNJ]GS5!*,@R1
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M@:DYHA:W/0MH[VA8)*.77%H1ZA*CS?*0"H^F2]V,#RM Y6IHG#S$4GBO@.)
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M_QOGX/"QE9K U=/I&8#.'68P9!N^R P6C8\U3[L[K[016*85&UL-[,SU3ZU
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MMI^Q3@/7!G&TO'S-SH@81C#2?2CFTD7&P="9:1K0CM Y9%MPSYRD/GMJJ/$
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MP&B6 Z'<;X_E6,L\Z>B-]NBLQ?-,C>949[XLSJ63CV0 1[4<X254)@L- ]W
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ML^_QORM>^^QX?'8\%AR/-C[[')G]%I%9D)]GAY_AR^/^Z<G>_P-02P,$%
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M3:%%KH+&96 JDF8K;+3J(1D\DGNJ4U""C%D"NU*YV"@VFZ?D^^B'K"ER)X4
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MBC/?EC@2HKH<7[5M<?X/VR@WP4%J^EA@WM[<GC'_S+N(6/(W4$L! A0#%
M  @ )3K94&;I82D\%0  09H   X              ( !     &0Y-#@T,C9D
M.&LN:'1M4$L! A0#%     @ )3K94"FU6);4'0  ;;X  !$
M ( !:!4  &0Y-#@T,C9D97@Q,#$N:'1M4$L! A0#%     @ )3K94-G<@'.J
M.@  )7X! !               ( !:S,  &0Y-#@T,C9D97@T,2YH=&U02P$"
M% ,4    "  E.ME0&*]5CV<X   '.@$ $               @ %#;@  9#DT
M.#0R-F1E>#0R+FAT;5!+ 0(4 Q0    ( "4ZV5!]OT$W>CH  $(M 0 0
M          "  =BF  !D.30X-#(V9&5X-#,N:'1M4$L! A0#%     @ )3K9
M4-MO;V'C$   BC4  !$              ( !@.$  &0Y-#@T,C9D97@Y.3$N
M:'1M4$L! A0#%     @ )3K94'^-N?MA P  (PP  !$              ( !
MDO(  &AS:6,M,C R,# V,C(N>'-D4$L! A0#%     @ )3K94-O>LP%E!@
M2$0  !4              ( !(O8  &AS:6,M,C R,# V,C)?;&%B+GAM;%!+
M 0(4 Q0    ( "4ZV5!>-HV7O 0   0K   5              "  ;K\  !H
J<VEC+3(P,C P-C(R7W!R92YX;6Q02P4&      D "0 Y @  J0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d948426d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d948426d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hsic-20200622_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hsic-20200622_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hsic-20200622.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hsic",
   "nsuri": "http://henryschein.com/20200622",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d948426d8k.htm",
      "contextRef": "duration_2020-06-22_to_2020-06-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d948426d8k.htm",
      "contextRef": "duration_2020-06-22_to_2020-06-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6628351328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 22, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HENRY SCHEIN INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001000228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 22,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-27078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3136595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">135 Duryea Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">843-5500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HSIC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d948426d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://henryschein.com//20200622/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d948426d8k.htm">d948426d8k.htm</File>
    <File>d948426dex101.htm</File>
    <File>d948426dex41.htm</File>
    <File>d948426dex42.htm</File>
    <File>d948426dex43.htm</File>
    <File>d948426dex991.htm</File>
    <File>hsic-20200622.xsd</File>
    <File>hsic-20200622_lab.xml</File>
    <File>hsic-20200622_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
